Advertisement

Mesenchymal Tumors of the Uterus

  • Esther Oliva
  • Charles J. Zaloudek
  • Robert A. Soslow
Living reference work entry

Abstract

This chapter deals with neoplasms of the uterus in which there is mesenchymal differentiation. Purely mesenchymal tumors, such as those derived from smooth muscle and endometrial stroma, are considered, as are some benign and malignant neoplasms containing mixtures of epithelium and connective tissue. The categories used here are slightly modified from the comprehensive classification of mesenchymal neoplasms of the uterus developed by the World Health Organization (WHO) (Kurman et al. 2014), shown in Table 1.

References

  1. Abeler VM, Nenodovic M (2011) Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases. Int J Gynecol Pathol 30:236–243.  https://doi.org/10.1097/PGP.0b013e318200caffCrossRefPubMedPubMedCentralGoogle Scholar
  2. Abeler VM, Royne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 54:355–364.  https://doi.org/10.1111/j.1365-2559.2009.03231.xCrossRefPubMedPubMedCentralGoogle Scholar
  3. Abell MR (1971) Papillary adenofibroma of the uterine cervix. Am J Obstet Gynecol 110:990–993PubMedCrossRefPubMedCentralGoogle Scholar
  4. Abrams J, Talcott J, Corson JM (1989) Pulmonary metastases in patients with low-grade endometrial stromal sarcoma. Clinicopathologic findings with immunohistochemical characterization. Am J Surg Pathol 13:133–140PubMedCrossRefPubMedCentralGoogle Scholar
  5. Abu-Rustum NR, Curtin JP, Burt M, Jones WB (1997) Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy. Obstet Gynecol 89:850–852PubMedCrossRefPubMedCentralGoogle Scholar
  6. Abushahin N, Zhang T, Chiang S, Zhang X, Hatch K, Zheng W (2011) Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases. Int J Gynecol Pathol 30:271–281.  https://doi.org/10.1097/PGP.0b013e318200868eCrossRefPubMedPubMedCentralGoogle Scholar
  7. Adamson GD (1992) Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists. Am J Obstet Gynecol 166:746–751PubMedCrossRefPubMedCentralGoogle Scholar
  8. Adany R, Fodor F, Molnar P, Ablin RJ, Muszbek L (1990) Increased density of histiocytes in uterine leiomyomas. Int J Gynecol Pathol 9:137–144PubMedCrossRefPubMedCentralGoogle Scholar
  9. Agaram NP et al (2015) Dichotomy of genetic abnormalities in PEComas with therapeutic implications. Am J Surg Pathol 39:813–825.  https://doi.org/10.1097/pas.0000000000000389CrossRefPubMedPubMedCentralGoogle Scholar
  10. Aggarwal N, Bhargava R, Elishaev E (2012) Uterine adenosarcomas: diagnostic use of the proliferation marker ki-67 as an adjunct to morphologic diagnosis. Int J Gynecol Pathol 31:447–452.  https://doi.org/10.1097/PGP.0b013e318249285bCrossRefPubMedPubMedCentralGoogle Scholar
  11. Agoff SN, Grieco VS, Garcia R, Gown AM (2001) Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol 9:164–169PubMedPubMedCentralGoogle Scholar
  12. Ahmad AK et al (2014) Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience. Int J Gynecol Cancer 24:1250–1255.  https://doi.org/10.1097/igc.0000000000000201CrossRefPubMedPubMedCentralGoogle Scholar
  13. Ahrens WA, Folpe AL (2011) CD1a immunopositivity in perivascular epithelioid cell neoplasms: true expression or technical artifact? A streptavidin-biotin and polymer-based detection system immunohistochemical study of perivascular epithelioid cell neoplasms and their morphologic mimics. Hum Pathol 42:369–374.  https://doi.org/10.1016/j.humpath.2010.09.001CrossRefPubMedPubMedCentralGoogle Scholar
  14. Aisagbonhi O, Harrison B, Zhao L, Osgood R, Chebib I, Oliva E (2017) YWHAE rearrangement in a purely conventional low-grade endometrial stromal sarcoma that transformed over time to high-grade sarcoma: importance of molecular testing. Int J Gynecol Pathol.  https://doi.org/10.1097/PGP.0000000000000451
  15. Akahira J et al (2006) Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma. Oncology 71:333–340.  https://doi.org/10.1159/000107107CrossRefPubMedPubMedCentralGoogle Scholar
  16. Akbulut M, Zekioglu O, Terek MC, Ozdemir N (2008) Lipoadenofibroma of the endometrium: a rare variant of benign mullerian mixed tumor. Arch Gynecol Obstet 278:283–286.  https://doi.org/10.1007/s00404-008-0572-0CrossRefPubMedPubMedCentralGoogle Scholar
  17. Albrektsen G, Heuch I, Wik E, Salvesen HB (2009) Prognostic impact of parity in 493 uterine sarcoma patients. Int J Gynecol Cancer 19:1062–1067.  https://doi.org/10.1111/IGC.0b013e3181aaa950. 00009577-200908000-00013 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  18. Ali RH et al (2014) Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait. Hum Pathol 45:2453–2462.  https://doi.org/10.1016/j.humpath.2014.08.012. S0046-8177(14)00356-6 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  19. Alsolami S et al (2014) Current morphologic criteria perform poorly in identifying hereditary leiomyomatosis and renal cell carcinoma syndrome-associated uterine leiomyomas. Int J Gynecol Pathol 33:560–567.  https://doi.org/10.1097/pgp.0000000000000091CrossRefPubMedPubMedCentralGoogle Scholar
  20. Amada S, Nakano H, Tsuneyoshi M (1995) Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 14:134–142PubMedCrossRefPubMedCentralGoogle Scholar
  21. Amant F et al (2004) Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma. Gynecol Oncol 93:680–685.  https://doi.org/10.1016/j.ygyno.2004.03.021. S0090825804001921 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  22. Amant F, Woestenborghs H, Vandenbroucke V, Berteloot P, Neven P, Moerman P, Vergote I (2006) Transition of endometrial stromal sarcoma into high-grade sarcoma. Gynecol Oncol 103:1137–1140.  https://doi.org/10.1016/j.ygyno.2006.07.013CrossRefPubMedPubMedCentralGoogle Scholar
  23. Amant F et al (2007) Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. Br J Cancer 97:1194–1199.  https://doi.org/10.1038/sj.bjc.6603986CrossRefPubMedPubMedCentralGoogle Scholar
  24. Amant F, Tousseyn T, Coenegrachts L, Decloedt J, Moerman P, Debiec-Rychter M (2011) Case report of a poorly differentiated uterine tumour with t(10;17) translocation and neuroectodermal phenotype. Anticancer Res 31:2367–2371. 31/6/2367 [pii]PubMedPubMedCentralGoogle Scholar
  25. American Cancer Society (2017) Survival rates of uterine sarcoma by stage. Cited 5 Jun 2017. www.cancer.org/cancer/uterine-sarcoma/detection-diagnosis-staging/survival-rates.html
  26. Andersen J (1998) Factors in fibroid growth. Baillieres Clin Obstet Gynaecol 12:225–243PubMedPubMedCentralGoogle Scholar
  27. Argani P et al (2001) Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159:179–192.  https://doi.org/10.1016/s0002-9440(10)61684-7CrossRefPubMedPubMedCentralGoogle Scholar
  28. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M (2003) Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27:750–761PubMedCrossRefPubMedCentralGoogle Scholar
  29. Argani P, Zhong M, Reuter VE, Fallon JT, Epstein JI, Netto GJ, Antonescu CR (2016) TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers. Am J Surg Pathol 40:723–737.  https://doi.org/10.1097/pas.0000000000000631CrossRefPubMedPubMedCentralGoogle Scholar
  30. Arias-Stella JA, Lewis N, Benayed R, Oliva E, Young R, Hoang L, Lee C-H, Jungbluth A, Soslow R, Antonescu C, Ladanyi M, Chiang S (2018) Novel PLAG1 gene rearrangement distinguishes uterine myxoid leiomyosarcoma from other uterine myxoid mesenchymal tumors. Paper presented at the United States and Canadian Academy of Pathology (USCAP) 107th annual meeting, VancouverGoogle Scholar
  31. Atkins KA, Bell ME, Kempson RL, Hendrickson MR (2001) Epithelioid smooth muscle neoplasms of the uterus. Mod Pathol 14:132AGoogle Scholar
  32. Atkins KA, Arronte N, Darus CJ, Rice LW (2008) The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol 32:98–102.  https://doi.org/10.1097/PAS.0b013e3181574d1eCrossRefPubMedPubMedCentralGoogle Scholar
  33. Attygalle AD et al (2017) An unusual case of YWHAE-NUTM2A/B endometrial stromal sarcoma with confinement to the endometrium and lack of high-grade morphology. Int J Gynecol Pathol 36:165–171.  https://doi.org/10.1097/PGP.0000000000000286CrossRefPubMedPubMedCentralGoogle Scholar
  34. Aubry MC, Myers JL, Colby TV, Leslie KO, Tazelaar HD (2002) Endometrial stromal sarcoma metastatic to the lung: a detailed analysis of 16 patients. Am J Surg Pathol 26:440–449PubMedCrossRefPubMedCentralGoogle Scholar
  35. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107PubMedCrossRefPubMedCentralGoogle Scholar
  36. Baker P, Oliva E (2007) Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques. J Clin Pathol 60:235–243PubMedPubMedCentralCrossRefGoogle Scholar
  37. Baker RJ, Hildebrandt RH, Rouse RV, Hendrickson MR, Longacre TA (1999) Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol 30:671–679PubMedCrossRefPubMedCentralGoogle Scholar
  38. Baker PM, Moch H, Oliva E (2005) Unusual morphologic features of endometrial stromal tumors: a report of 2 cases. Am J Surg Pathol 29:1394–1398. 00000478-200510000-00018 [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  39. Baldi GG et al (2013) Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients. Clin Sarcoma Res 3:4.  https://doi.org/10.1186/2045-3329-3-4CrossRefPubMedPubMedCentralGoogle Scholar
  40. Balleine RL, Earls PJ, Webster LR, Mote PA, deFazio A, Harnett PR, Clarke CL (2004) Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma. Int J Gynecol Pathol 23:138–144. 00004347-200404000-00008 [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  41. Bardella C et al (2011) Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. J Pathol 225:4–11.  https://doi.org/10.1002/path.2932CrossRefPubMedPubMedCentralGoogle Scholar
  42. Barlin JN et al (2015) Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome. Neoplasia 17:183–189.  https://doi.org/10.1016/j.neo.2014.12.007CrossRefPubMedPubMedCentralGoogle Scholar
  43. Barlow JF et al (1983) Myxoid tumor of the uterus and right atrial myxomas. S D J Med 36:9–13PubMedPubMedCentralGoogle Scholar
  44. Barney B, Tward JD, Skidmore T, Gaffney DK (2009) Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma? Int J Gynecol Cancer 19:1232–1238.  https://doi.org/10.1111/IGC.0b013e3181b33c9a. 00009577-200910000-00015 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  45. Bartosch C, Exposito MI, Lopes JM (2010) Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups. Int J Surg Pathol 18:286–291.  https://doi.org/10.1177/1066896909337600CrossRefPubMedPubMedCentralGoogle Scholar
  46. Beer TW, Buchanan R, Buckley CH (1995) Uterine stromal sarcoma following tamoxifen treatment. J Clin Pathol 48:596PubMedPubMedCentralCrossRefGoogle Scholar
  47. Bekkers RL, Willemsen WN, Schijf CP, Massuger LF, Bulten J, Merkus JM (1999) Leiomyomatosis peritonealis disseminata: does malignant transformation occur? A literature review. Gynecol Oncol 75:158–163.  https://doi.org/10.1006/gyno.1999.5490CrossRefPubMedPubMedCentralGoogle Scholar
  48. Bell SW, Kempson RL, Hendrickson MR (1994) Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18:535–558PubMedCrossRefPubMedCentralGoogle Scholar
  49. Bennett JA, Lamb C, Young RH (2016) Apoplectic leiomyomas: a morphologic analysis of 100 cases highlighting unusual features. Am J Surg Pathol 40:563–568.  https://doi.org/10.1097/pas.0000000000000569CrossRefPubMedPubMedCentralGoogle Scholar
  50. Bennett JA, Nardi V, Rouzbahman M, Morales-Oyarvide V, Nielsen GP, Oliva E (2017a) Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum. Mod Pathol 30:1489–1503.  https://doi.org/10.1038/modpathol.2017.69CrossRefPubMedPubMedCentralGoogle Scholar
  51. Bennett JA et al (2017b) Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases. Mod Pathol 30:1476–1488.  https://doi.org/10.1038/modpathol.2017.56CrossRefPubMedPubMedCentralGoogle Scholar
  52. Bergeron C, Amant F, Ferenczy A (2006) Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20:511–521PubMedCrossRefPubMedCentralGoogle Scholar
  53. Bernard B et al (2013) Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival. Gynecol Oncol 131:634–639.  https://doi.org/10.1016/j.ygyno.2013.09.011CrossRefPubMedPubMedCentralGoogle Scholar
  54. Bertsch E et al (2014) MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol 27:1144–1153.  https://doi.org/10.1038/modpathol.2013.243CrossRefPubMedPubMedCentralGoogle Scholar
  55. Binder SW, Nieberg RK, Cheng L, al-Jitawi S (1991) Histologic and immunohistochemical analysis of nine endometrial stromal tumors: an unexpected high frequency of keratin protein positivity. Int J Gynecol Pathol 10:191–197PubMedCrossRefPubMedCentralGoogle Scholar
  56. Blake EA, Sheridan TB, Wang KL, Takiuchi T, Kodama M, Sawada K, Matsuo K (2014) Clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature. Eur J Obstet Gynecol Reprod Biol 181:163–170.  https://doi.org/10.1016/j.ejogrb.2014.07.050CrossRefPubMedPubMedCentralGoogle Scholar
  57. Blattner JM, Gable P, Quigley MM, McHale MT (2007) Primitive neuroectodermal tumor of the uterus. Gynecol Oncol 106:419–422PubMedCrossRefPubMedCentralGoogle Scholar
  58. Blom R, Guerrieri C (1999) Adenosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 11 cases. Int J Gynecol Cancer 9:37–43PubMedCrossRefPubMedCentralGoogle Scholar
  59. Blom R, Guerrieri C, Stal O, Malmstrom H, Simonsen E (1998) Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases. Gynecol Oncol 68:54–61PubMedCrossRefPubMedCentralGoogle Scholar
  60. Bodner K et al (2001) Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 81:160–165.  https://doi.org/10.1006/gyno.2001.6152. S0090-8258(01)96152-9 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  61. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Mayerhofer K (2004) Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Fertil Steril 81:1062–1066.  https://doi.org/10.1016/j.fertnstert.2003.08.043CrossRefPubMedPubMedCentralGoogle Scholar
  62. Bodner-Adler B, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K (2005) Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis. Gynecol Oncol 96:62–66.  https://doi.org/10.1016/j.ygyno.2004.09.026CrossRefPubMedPubMedCentralGoogle Scholar
  63. Bogani G et al (2016) Morcellator’s port-site metastasis of a uterine smooth muscle tumor of uncertain malignant potential after minimally invasive myomectomy. J Minim Invasive Gynecol 23:647–649.  https://doi.org/10.1016/j.jmig.2016.01.021CrossRefPubMedPubMedCentralGoogle Scholar
  64. Borahay MA, Al-Hendy A, Kilic GS, Boehning D (2015) Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy. Mol Med 21:242–256.  https://doi.org/10.2119/molmed.2014.00053CrossRefPubMedPubMedCentralGoogle Scholar
  65. Botsis D, Koliopoulos C, Kondi-Pafitis A, Creatsas G (2005) Frequency, histological, and immunohistochemical properties of massive inflammatory lymphocytic infiltration of leiomyomas of the uterus: an entity causing diagnostic difficulties. Int J Gynecol Pathol 24:326–329PubMedCrossRefPubMedCentralGoogle Scholar
  66. Bouchard-Fortier G, Kim RH, Allen L, Gupta A, May T (2016) Fertility-sparing surgery for the management of young women with embryonal rhabdomyosarcoma of the cervix: a case series. Gynecol Oncol Rep 18:4–7.  https://doi.org/10.1016/j.gore.2016.08.004CrossRefPubMedPubMedCentralGoogle Scholar
  67. Brescia RJ, Tazelaar HD, Hobbs J, Miller AW (1989) Intravascular lipoleiomyomatosis: a report of two cases. Hum Pathol 20:252–256PubMedCrossRefPubMedCentralGoogle Scholar
  68. Brooks JJ, Wells GB, Yeh IT, LiVolsi VA (1992) Bizarre epithelioid lipoleiomyoma of the uterus. Int J Gynecol Pathol 11:144–149PubMedCrossRefPubMedCentralGoogle Scholar
  69. Brooks SE, Zhan M, Cote T, Baquet CR (2004) Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol 93:204–208.  https://doi.org/10.1016/j.ygyno.2003.12.029CrossRefPubMedPubMedCentralGoogle Scholar
  70. Brown DC, Theaker JM, Banks PM, Gatter KC, Mason DY (1987) Cytokeratin expression in smooth muscle and smooth muscle tumours. Histopathology 11:477–486PubMedCrossRefPubMedCentralGoogle Scholar
  71. Buelow B, Cohen J, Nagymanyoki Z, Frizzell N, Joseph NM, McCalmont T, Garg K (2016) Immunohistochemistry for 2-Succinocysteine (2SC) and fumarate hydratase (FH) in cutaneous leiomyomas may aid in identification of patients with HLRCC (Hereditary leiomyomatosis and renal cell carcinoma syndrome). Am J Surg Pathol 40:982–988.  https://doi.org/10.1097/pas.0000000000000626CrossRefPubMedPubMedCentralGoogle Scholar
  72. Bukulmez O, Doody KJ (2006) Clinical features of myomas. Obstet Gynecol Clin N Am 33:69–84.  https://doi.org/10.1016/j.ogc.2005.12.002CrossRefGoogle Scholar
  73. Burch DM, Tavassoli FA (2011) Myxoid leiomyosarcoma of the uterus. Histopathology 59:1144–1155.  https://doi.org/10.1111/j.1365-2559.2011.04053.xCrossRefPubMedPubMedCentralGoogle Scholar
  74. Busca A, Parra-Herran C (2016) Hemangiomas of the uterine cervix: association with abnormal bleeding and pain in young women and hormone receptor expression. Report of four cases and review of the literature. Pathol Res Pract 212:532–538.  https://doi.org/10.1016/j.prp.2016.03.003CrossRefPubMedPubMedCentralGoogle Scholar
  75. Busca A, Parra-Herran C (2017) Myxoid mesenchymal tumors of the uterus: an update on classification, definitions, and differential diagnosis. Adv Anat Pathol 24:354–361.  https://doi.org/10.1097/pap.0000000000000164CrossRefPubMedPubMedCentralGoogle Scholar
  76. Busca A, Gulavita P, Parra-Herran C, Islam S (2017) IFITM1 outperforms CD10 in differentiating low-grade endometrial stromal sarcomas from smooth muscle neoplasms of the uterus. Int J Gynecol Pathol.  https://doi.org/10.1097/PGP.0000000000000424PubMedCrossRefPubMedCentralGoogle Scholar
  77. Buza N, Xu F, Wu W, Carr RJ, Li P, Hui P (2014) Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study. Hum Pathol 45:1885–1892.  https://doi.org/10.1016/j.humpath.2014.05.010CrossRefPubMedPubMedCentralGoogle Scholar
  78. Cardinale L, Mirra M, Galli C, Goldblum JR, Pizzolitto S, Falconieri G (2008) Angiosarcoma of the uterus: report of 2 new cases with deviant clinicopathologic features and review of the literature. Ann Diagn Pathol 12:217–221.  https://doi.org/10.1016/j.anndiagpath.2007.08.001. S1092-9134(07)00123-2 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  79. Carroll A et al (2014) Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence. Gynecol Oncol 135:455–461.  https://doi.org/10.1016/j.ygyno.2014.10.022CrossRefPubMedPubMedCentralGoogle Scholar
  80. Casey S, McCluggage WG (2015) Adenomyomas of the uterine cervix: report of a cohort including endocervical and novel variants [corrected]. Histopathology 66:420–429.  https://doi.org/10.1111/his.12546CrossRefPubMedPubMedCentralGoogle Scholar
  81. Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS (2008) Endometrial stromal sarcoma: a population-based analysis. Br J Cancer 99:1210–1215.  https://doi.org/10.1038/sj.bjc.6604527CrossRefPubMedPubMedCentralGoogle Scholar
  82. Chang V, Aikawa M, Druet R (1977) Uterine leiomyoblastoma: ultrastructural and cytological studies. Cancer 39:1563–1569PubMedCrossRefPubMedCentralGoogle Scholar
  83. Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL, Hendrickson MR (1990) Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 14:415–438PubMedCrossRefPubMedCentralGoogle Scholar
  84. Charville GW et al (2016) PAX7 expression in rhabdomyosarcoma, related soft tissue tumors, and small round blue cell neoplasms. Am J Surg Pathol 40:1305–1315.  https://doi.org/10.1097/pas.0000000000000717CrossRefPubMedPubMedCentralGoogle Scholar
  85. Chauveinc L et al (1999) Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments. Gynecol Oncol 72:232–237.  https://doi.org/10.1006/gyno.1998.5251. S0090-8258(98)95251-9 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  86. Chen KT (1999) Uterine leiomyohibernoma. Int J Gynecol Pathol 18:96–97PubMedCrossRefPubMedCentralGoogle Scholar
  87. Chen L, Yang B (2008) Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol 27:326–332.  https://doi.org/10.1097/PGP.0b013e31815ea7f5CrossRefPubMedPubMedCentralGoogle Scholar
  88. Cheung AN, Ng WF, Chung LP, Khoo US (1996) Mixed low grade and high grade endometrial stromal sarcoma of uterus: differences on immunohistochemistry and chromosome in situ hybridisation. J Clin Pathol 49:604–607PubMedPubMedCentralCrossRefGoogle Scholar
  89. Chew I, Oliva E (2010) Endometrial stromal sarcomas: a review of potential prognostic factors. Adv Anat Pathol 17:113–121.  https://doi.org/10.1097/PAP.0b013e3181cfb7c2. 00125480-201003000-00003 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  90. Chiang S et al (2011) Frequency of known gene rearrangements in endometrial stromal tumors. Am J Surg Pathol 35:1364–1372.  https://doi.org/10.1097/PAS.0b013e3182262743CrossRefPubMedPubMedCentralGoogle Scholar
  91. Chiang S et al (2015) FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors. Am J Surg Pathol 39:618–623.  https://doi.org/10.1097/pas.0000000000000367CrossRefPubMedPubMedCentralGoogle Scholar
  92. Chiang S et al (2017a) BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol 30:1251–1261.  https://doi.org/10.1038/modpathol.2017.42CrossRefPubMedPubMedCentralGoogle Scholar
  93. Chiang S et al (2017b) Primitive neuroectodermal tumors of the female genital tract: a morphologic, immunohistochemical, and molecular study of 19 cases. Am J Surg Pathol 41:761–772.  https://doi.org/10.1097/pas.0000000000000831CrossRefPubMedPubMedCentralGoogle Scholar
  94. Chiang S et al (2018) NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma. Am J Surg Pathol 42:791–798.  https://doi.org/10.1097/pas.0000000000001055CrossRefPubMedPubMedCentralGoogle Scholar
  95. Cho KR, Woodruff JD, Epstein JI (1989) Leiomyoma of the uterus with multiple extrauterine smooth muscle tumors: a case report suggesting multifocal origin. Hum Pathol 20:80–83PubMedCrossRefPubMedCentralGoogle Scholar
  96. Choi YJ et al (2015) Genomic landscape of endometrial stromal sarcoma of uterus. Oncotarget 6:33319–33328.  https://doi.org/10.18632/oncotarget.5384CrossRefPubMedPubMedCentralGoogle Scholar
  97. Chou WY, Chang HW (2012) Uterine hemangioma: a rare pathologic entity. Arch Pathol Lab Med 136:567–571.  https://doi.org/10.5858/arpa.2011-0078-RSCrossRefPubMedPubMedCentralGoogle Scholar
  98. Chow KL et al (2017) The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study. Histopathology 70:746–755.  https://doi.org/10.1111/his.13124CrossRefPubMedPubMedCentralGoogle Scholar
  99. Christacos NC, Quade BJ, Dal Cin P, Morton CC (2006) Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer 45:304–312.  https://doi.org/10.1002/gcc.20291CrossRefPubMedPubMedCentralGoogle Scholar
  100. Chu P, Arber DA (2000) Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 113:374–382.  https://doi.org/10.1309/8vav-j2fu-8cu9-ek18CrossRefPubMedPubMedCentralGoogle Scholar
  101. Chu PG, Arber DA, Weiss LM, Chang KL (2001) Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol 14:465–471.  https://doi.org/10.1038/modpathol.3880335CrossRefPubMedPubMedCentralGoogle Scholar
  102. Chu MC, Mor G, Lim C, Zheng W, Parkash V, Schwartz PE (2003) Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 90:170–176. S0090825803002580 [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  103. Clement PB (1988) Intravenous leiomyomatosis of the uterus. Pathol Annu 23 Pt 2:153–183PubMedPubMedCentralGoogle Scholar
  104. Clement PB (1989) Mullerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases. Am J Surg Pathol 13:28–38PubMedCrossRefPubMedCentralGoogle Scholar
  105. Clement PB (2000) The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a selective review with emphasis on recent advances. Int J Gynecol Pathol 19:39–55PubMedCrossRefPubMedCentralGoogle Scholar
  106. Clement PB (2007) The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects. Adv Anat Pathol 14:241–260.  https://doi.org/10.1097/PAP.0b013e3180ca7d7bCrossRefPubMedPubMedCentralGoogle Scholar
  107. Clement PB, Scully RE (1974) Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of mullerian mixed tumor. Cancer 34:1138–1149PubMedCrossRefPubMedCentralGoogle Scholar
  108. Clement PB, Scully RE (1976) Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of fourteen cases. Am J Clin Pathol 66:512–525PubMedCrossRefPubMedCentralGoogle Scholar
  109. Clement PB, Scully RE (1989) Mullerian adenosarcomas of the uterus with sex cord-like elements. A clinicopathologic analysis of eight cases. Am J Clin Pathol 91:664–672PubMedCrossRefPubMedCentralGoogle Scholar
  110. Clement PB, Scully RE (1990a) Mullerian adenofibroma of the uterus with invasion of myometrium and pelvic veins. Int J Gynecol Pathol 9:363–371PubMedCrossRefPubMedCentralGoogle Scholar
  111. Clement PB, Scully RE (1990b) Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21:363–381PubMedCrossRefPubMedCentralGoogle Scholar
  112. Clement PB, Scully RE (1992) Endometrial stromal sarcomas of the uterus with extensive endometrioid glandular differentiation: a report of three cases that caused problems in differential diagnosis. Int J Gynecol Pathol 11:163–173PubMedCrossRefPubMedCentralGoogle Scholar
  113. Clement PB, Young RH, Scully RE (1988) Intravenous leiomyomatosis of the uterus. A clinicopathological analysis of 16 cases with unusual histologic features. Am J Surg Pathol 12:932–945PubMedCrossRefPubMedCentralGoogle Scholar
  114. Clement PB, Young RH, Scully RE (1992) Diffuse, perinodular, and other patterns of hydropic degeneration within and adjacent to uterine leiomyomas. Problems in differential diagnosis. Am J Surg Pathol 16:26–32PubMedCrossRefPubMedCentralGoogle Scholar
  115. Coad JE, Sulaiman RA, Das K, Staley N (1997) Perinodular hydropic degeneration of a uterine leiomyoma: a diagnostic challenge. Hum Pathol 28:249–251PubMedCrossRefPubMedCentralGoogle Scholar
  116. Coard KC, Fletcher HM (2002) Leiomyosarcoma of the uterus with a florid intravascular component (“intravenous leiomyosarcomatosis”). Int J Gynecol Pathol 21:182–185PubMedCrossRefPubMedCentralGoogle Scholar
  117. Cohen DT, Oliva E, Hahn PF, Fuller AF Jr, Lee SI (2007) Uterine smooth-muscle tumors with unusual growth patterns: imaging with pathologic correlation. AJR Am J Roentgenol 188:246–255.  https://doi.org/10.2214/ajr.05.1070CrossRefPubMedPubMedCentralGoogle Scholar
  118. Conlon N, Soslow RA, Murali R (2015) Perivascular epithelioid tumours (PEComas) of the gynaecological tract. J Clin Pathol 68:418–426.  https://doi.org/10.1136/jclinpath-2015-202945CrossRefPubMedPubMedCentralGoogle Scholar
  119. Cramer SF, Patel A (1990) The frequency of uterine leiomyomas. Am J Clin Pathol 94:435–438PubMedCrossRefPubMedCentralGoogle Scholar
  120. Cramer SF, Horiszny J, Patel A, Sigrist S (1996) The relation of fibrous degeneration to menopausal status in small uterine leiomyomas with evidence for postmenopausal origin of seedling myomas. Mod Pathol 9:774–780PubMedPubMedCentralGoogle Scholar
  121. Croce S, Chibon F (2015) MED12 and uterine smooth muscle oncogenesis: state of the art and perspectives. Eur J Cancer 51:1603–1610.  https://doi.org/10.1016/j.ejca.2015.04.023CrossRefPubMedPubMedCentralGoogle Scholar
  122. Croce S et al (2013) YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations. Mod Pathol 26:1390–1400.  https://doi.org/10.1038/modpathol.2013.69CrossRefPubMedPubMedCentralGoogle Scholar
  123. Croce S, Young RH, Oliva E (2014) Uterine leiomyomas with bizarre nuclei: a clinicopathologic study of 59 cases. Am J Surg Pathol 38:1330–1339.  https://doi.org/10.1097/pas.0000000000000249CrossRefPubMedPubMedCentralGoogle Scholar
  124. Croce S et al (2015) Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions. Mod Pathol 28:1001–1010.  https://doi.org/10.1038/modpathol.2015.3CrossRefPubMedPubMedCentralGoogle Scholar
  125. Croce S, de Kock L, Boshari T, Hostein I, Velasco V, Foulkes WD, McCluggage WG (2016) Uterine tumor resembling ovarian sex cord tumor (UTROSCT) commonly exhibits positivity with sex cord markers FOXL2 and SF-1 but lacks FOXL2 and DICER1 mutations. Int J Gynecol Pathol 35:301–308.  https://doi.org/10.1097/pgp.0000000000000240CrossRefPubMedPubMedCentralGoogle Scholar
  126. Crow J, Wilkins M, Howe S, More L, Helliwell P (1991) Mast cells in the female genital tract. Int J Gynecol Pathol 10:230–237PubMedCrossRefPubMedCentralGoogle Scholar
  127. Cui RR, Wright JD (2016) Risk of occult uterine sarcoma in presumed uterine fibroids. Clin Obstet Gynecol 59:103–118.  https://doi.org/10.1097/grf.0000000000000163CrossRefPubMedPubMedCentralGoogle Scholar
  128. D’Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116:131–139.  https://doi.org/10.1016/j.ygyno.2009.09.023. S0090-8258(09)00722-7 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  129. D’Angelo E, Ali RH, Espinosa I, Lee CH, Huntsman DG, Gilks B, Prat J (2013) Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement. Am J Surg Pathol 37:514–521.  https://doi.org/10.1097/PAS.0b013e318272c612CrossRefPubMedPubMedCentralGoogle Scholar
  130. Dal Cin P, Aly MS, De Wever I, Moerman P, Van Den Berghe H (1992) Endometrial stromal sarcoma t(7;17)(p15-21;q12-21) is a nonrandom chromosome change. Cancer Genet Cytogenet 63:43–46. 0165-4608(92)90062-D [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  131. Darby AJ, Papadaki L, Beilby JO (1975) An unusual leiomyosarcoma of the uterus containing osteoclast-like giant cells. Cancer 36:495–504PubMedCrossRefPubMedCentralGoogle Scholar
  132. Davidson B et al (2014) Gene expression signatures of primary and metastatic uterine leiomyosarcoma. Hum Pathol 45:691–700.  https://doi.org/10.1016/j.humpath.2013.11.003CrossRefPubMedPubMedCentralGoogle Scholar
  133. Daya DA, Scully RE (1988) Sarcoma botryoides of the uterine cervix in young women: a clinicopathological study of 13 cases. Gynecol Oncol 29:290–304PubMedCrossRefPubMedCentralGoogle Scholar
  134. De Fusco PA, Gaffey TA, Malkasian GD Jr, Long HJ, Cha SS (1989) Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945–1980. Gynecol Oncol 35:8–14PubMedCrossRefPubMedCentralGoogle Scholar
  135. de Leval L, Waltregny D, Boniver J, Young RH, Castronovo V, Oliva E (2006) Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus. Am J Surg Pathol 30:319–327.  https://doi.org/10.1097/01.pas.0000188029.63706.31. 00000478-200603000-00004 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  136. de Leval L, Lim GS, Waltregny D, Oliva E (2010) Diverse phenotypic profile of uterine tumors resembling ovarian sex cord tumors: an immunohistochemical study of 12 cases. Am J Surg Pathol 34:1749–1761.  https://doi.org/10.1097/PAS.0b013e3181f8120cCrossRefPubMedPubMedCentralGoogle Scholar
  137. de Vos S, Wilczynski SP, Fleischhacker M, Koeffler P (1994) p53 alterations in uterine leiomyosarcomas versus leiomyomas. Gynecol Oncol 54:205–208.  https://doi.org/10.1006/gyno.1994.1194CrossRefPubMedPubMedCentralGoogle Scholar
  138. Dehner LP, Jarzembowski JA, Hill DA (2012) Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations. Mod Pathol 25:602–614.  https://doi.org/10.1038/modpathol.2011.185CrossRefPubMedPubMedCentralGoogle Scholar
  139. Devaney K, Tavassoli FA (1991) Immunohistochemistry as a diagnostic aid in the interpretation of unusual mesenchymal tumors of the uterus. Mod Pathol 4:225–231PubMedPubMedCentralGoogle Scholar
  140. Dewaele B et al (2014) Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma. Int J Cancer 134:1112–1122.  https://doi.org/10.1002/ijc.28440CrossRefPubMedPubMedCentralGoogle Scholar
  141. Dgani R et al (1998) Clinical-pathological study of uterine leiomyomas with high mitotic activity. Acta Obstet Gynecol Scand 77:74–77PubMedPubMedCentralGoogle Scholar
  142. Dharkar DD, Kraft JR, Gangadharam D (1981) Uterine lipomas. Arch Pathol Lab Med 105:43–45PubMedPubMedCentralGoogle Scholar
  143. Dimmler A, Seitz G, Hohenberger W, Kirchner T, Faller G (2003) Late pulmonary metastasis in uterine PEComa. J Clin Pathol 56:627–628PubMedPubMedCentralCrossRefGoogle Scholar
  144. Dionigi A, Oliva E, Clement PB, Young RH (2002) Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases. Am J Surg Pathol 26:567–581PubMedCrossRefPubMedCentralGoogle Scholar
  145. Dos Santos LA et al (2011) Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma. Gynecol Oncol 121:319–322.  https://doi.org/10.1016/j.ygyno.2010.12.363. S0090-8258(10)01270-9 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  146. Downes KA, Hart WR (1997) Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol 21:1261–1270PubMedCrossRefPubMedCentralGoogle Scholar
  147. Due W, Pickartz H (1989) Immunohistologic detection of estrogen and progesterone receptors in disseminated peritoneal leiomyomatosis. Int J Gynecol Pathol 8:46–53PubMedCrossRefPubMedCentralGoogle Scholar
  148. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F (2002) Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 186:409–415PubMedCrossRefPubMedCentralGoogle Scholar
  149. Dundr P, Mara M, Maskova J, Fucikova Z, Povysil C, Tvrdik D (2006) Pathological findings of uterine leiomyomas and adenomyosis following uterine artery embolization. Pathol Res Pract 202:721–729.  https://doi.org/10.1016/j.prp.2006.07.001CrossRefPubMedPubMedCentralGoogle Scholar
  150. Eddy GL, Mazur MT (1997) Endolymphatic stromal myosis associated with tamoxifen use. Gynecol Oncol 64:262–264.  https://doi.org/10.1006/gyno.1996.4552. S0090-8258(96)94552-7 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  151. Eichhorn JH, Young RH, Clement PB (1996) Sertoliform endometrial adenocarcinoma: a study of four cases. Int J Gynecol Pathol 15:119–126PubMedCrossRefPubMedCentralGoogle Scholar
  152. Elshafie M, Rahimi S, Ganesan R, Hirschowitz L (2013) Mullerian adenosarcoma arising in a subserosal adenomyoma. Int J Surg Pathol 21:186–189.  https://doi.org/10.1177/1066896912453852CrossRefPubMedPubMedCentralGoogle Scholar
  153. Euscher ED, Deavers MT, Lopez-Terrada D, Lazar AJ, Silva EG, Malpica A (2008) Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol 32:219–228.  https://doi.org/10.1097/PAS.0b013e318093e421CrossRefPubMedPubMedCentralGoogle Scholar
  154. Evans HL (1982) Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50:2170–2182PubMedCrossRefPubMedCentralGoogle Scholar
  155. Evans AT 3rd, Symmonds RE, Gaffey TA (1981) Recurrent pelvic intravenous leiomyomatosis. Obstet Gynecol 57:260–264PubMedPubMedCentralGoogle Scholar
  156. Evans HL, Chawla SP, Simpson C, Finn KP (1988) Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 62:2239–2247PubMedCrossRefPubMedCentralGoogle Scholar
  157. Eyden BP, Hale RJ, Richmond I, Buckley CH (1992) Cytoskeletal filaments in the smooth muscle cells of uterine leiomyomata and myometrium: an ultrastructural and immunohistochemical analysis. Virchows Arch A Pathol Anat Histopathol 420:51–58PubMedCrossRefPubMedCentralGoogle Scholar
  158. Fadare O (2008) Perivascular epithelioid cell tumor (PEComa) of the uterus: an outcome-based clinicopathologic analysis of 41 reported cases. Adv Anat Pathol 15:63–75.  https://doi.org/10.1097/PAP.0b013e31816613b0CrossRefPubMedPubMedCentralGoogle Scholar
  159. Fadare O (2011) Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review. Adv Anat Pathol 18:60–74.  https://doi.org/10.1097/PAP.0b013e3182026be7CrossRefPubMedPubMedCentralGoogle Scholar
  160. Fadare O, McCalip B, Mariappan MR, Hileeto D, Parkash V (2005) An endometrial stromal tumor with osteoclast-like giant cells. Ann Diagn Pathol 9:160–165. S109291340500033X [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  161. Fadare O, Bonvicino A, Martel M, Renshaw IL, Azodi M, Parkash V (2010) Pleomorphic rhabdomyosarcoma of the uterine corpus: a clinicopathologic study of 4 cases and a review of the literature. Int J Gynecol Pathol 29:122–134.  https://doi.org/10.1097/PGP.0b013e3181bc98c0. 00004347-201003000-00005 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  162. Farhood AI, Abrams J (1991) Immunohistochemistry of endometrial stromal sarcoma. Hum Pathol 22:224–230PubMedCrossRefPubMedCentralGoogle Scholar
  163. Fekete PS, Vellios F (1984) The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases. Int J Gynecol Pathol 3:198–212PubMedCrossRefPubMedCentralGoogle Scholar
  164. Felix AS et al (2013) The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer 108:727–734.  https://doi.org/10.1038/bjc.2013.2CrossRefPubMedPubMedCentralGoogle Scholar
  165. Feng W, Hua K, Malpica A, Zhou X, Baak JP (2013a) Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough? Int J Gynecol Cancer 23:488–493.  https://doi.org/10.1097/IGC.0b013e318247aa14. 00009577-201303000-00015 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  166. Feng W, Malpica A, Robboy SJ, Gudlaugsson E, Hua K, Zhou X, Baak JP (2013b) Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family. Int J Gynecol Pathol 32:299–306.  https://doi.org/10.1097/PGP.0b013e318229adfbCrossRefPubMedPubMedCentralGoogle Scholar
  167. Feng W et al (2013c) Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? PLoS One 8:e75899.  https://doi.org/10.1371/journal.pone.0075899. PONE-D-13-18388 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  168. Feng W, Malpica A, Yinhua Y, Janssen E, Gudlaugsson E, Zhou X, Baak JP (2013d) Diagnostic and prognostic morphometric features in WHO 2003 invasive endometrial stromal tumours. Histopathology 62:688–694.  https://doi.org/10.1111/j.1365-2559.2011.04120.xCrossRefPubMedPubMedCentralGoogle Scholar
  169. Ferguson SE, Gerald W, Barakat RR, Chi DS, Soslow RA (2007) Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults. Am J Surg Pathol 31:382–389PubMedCrossRefPubMedCentralGoogle Scholar
  170. Ferry JA, Harris NL, Scully RE (1989) Uterine leiomyomas with lymphoid infiltration simulating lymphoma: a report of seven cases. Int J Gynecol Pathol 8:263–270PubMedCrossRefPubMedCentralGoogle Scholar
  171. Fitko R, Brainer J, Schink JC, August CZ (1990) Endometrial stromal sarcoma with rhabdoid differentiation. Int J Gynecol Pathol 9:379–382PubMedCrossRefPubMedCentralGoogle Scholar
  172. Fleming WP, Peters WA, Kumar NB, Morley GW (1984) Autopsy findings in patients with uterine sarcoma. Gynecol Oncol 19:168–172PubMedCrossRefPubMedCentralGoogle Scholar
  173. Fleming H, Ostor AG, Pickel H, Fortune DW (1989) Arteriovenous malformations of the uterus. Obstet Gynecol 73:209–214PubMedPubMedCentralGoogle Scholar
  174. Flicker K, Smolle E, Haybaeck J, Moinfar F (2015) Genomic characterization of endometrial stromal sarcomas with array comparative genomic hybridization. Exp Mol Pathol 98:367–374.  https://doi.org/10.1016/j.yexmp.2015.03.009. S0014-4800(15)00044-1 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  175. Flierman PA, Oberye JJ, van der Hulst VP, de Blok S (2005) Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix. BJOG 112:638–642.  https://doi.org/10.1111/j.1471-0528.2004.00504.xCrossRefPubMedPubMedCentralGoogle Scholar
  176. Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW (2005) Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 29:1558–1575PubMedCrossRefPubMedCentralGoogle Scholar
  177. Fornelli A, Pasquinelli G, Eusebi V (1999) Leiomyoma of the uterus showing skeletal muscle differentiation: a case report. Hum Pathol 30:356–359PubMedCrossRefPubMedCentralGoogle Scholar
  178. Franquemont DW, Frierson HF Jr, Mills SE (1991) An immunohistochemical study of normal endometrial stroma and endometrial stromal neoplasms. Evidence for smooth muscle differentiation. Am J Surg Pathol 15:861–870PubMedCrossRefPubMedCentralGoogle Scholar
  179. Frey NV et al (2006) Primary lymphomas of the cervix and uterus: the University of Pennsylvania’s experience and a review of the literature. Leuk Lymphoma 47:1894–1901.  https://doi.org/10.1080/10428190600687653. U8R528Q43L276436 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  180. Fuehrer NE, Keeney GL, Ketterling RP, Knudson RA, Bell DA (2012) ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract. Arch Pathol Lab Med 136:623–626.  https://doi.org/10.5858/arpa.2011-0341-OACrossRefPubMedPubMedCentralGoogle Scholar
  181. Fukunaga M (2005) Perivascular epithelioid cell tumor of the uterus: report of four cases. Int J Gynecol Pathol 24:341–346PubMedCrossRefPubMedCentralGoogle Scholar
  182. Fukunaga M (2011) Pure alveolar rhabdomyosarcoma of the uterine corpus. Pathol Int 61:377–381.  https://doi.org/10.1111/j.1440-1827.2011.02672.xCrossRefPubMedPubMedCentralGoogle Scholar
  183. Fukunaga M, Endo Y (1996) Pelvic bone involvement in low-grade endometrial stromal sarcoma with ovarian sex cord-like differentiation. Histopathology 29:391–393PubMedCrossRefPubMedCentralGoogle Scholar
  184. Fukunaga M, Ushigome S (1998) Dissecting leiomyoma of the uterus with extrauterine extension. Histopathology 32:160–164PubMedCrossRefPubMedCentralGoogle Scholar
  185. Fukunaga M, Miyazawa Y, Ushigome S (1997) Endometrial low-grade stromal sarcoma with ovarian sex cord-like differentiation: report of two cases with an immunohistochemical and flow cytometric study. Pathol Int 47:412–415PubMedCrossRefPubMedCentralGoogle Scholar
  186. Gadducci A et al (1996a) Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol 62:25–32.  https://doi.org/10.1006/gyno.1996.0185CrossRefPubMedPubMedCentralGoogle Scholar
  187. Gadducci A et al (1996b) Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 63:247–253.  https://doi.org/10.1006/gyno.1996.0314. S0090-8258(96)90314-5 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  188. Gadducci A, Cosio S, Romanini A, Genazzani AR (2008) The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 65:129–142.  https://doi.org/10.1016/j.critrevonc.2007.06.011CrossRefPubMedPubMedCentralGoogle Scholar
  189. Gal AA, Brooks JS, Pietra GG (1989) Leiomyomatous neoplasms of the lung: a clinical, histologic, and immunohistochemical study. Mod Pathol 2:209–216PubMedPubMedCentralGoogle Scholar
  190. Gallardo A, Prat J (2009) Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol 33:278–288.  https://doi.org/10.1097/PAS.0b013e318181a80dCrossRefPubMedPubMedCentralGoogle Scholar
  191. Gannon BR, Manduch M, Childs TJ (2008) Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants. Int J Gynecol Pathol 27:68–73.  https://doi.org/10.1097/pgp.0b013e3180ca954fCrossRefPubMedPubMedCentralGoogle Scholar
  192. Garcia MG, Deavers MT, Knoblock RJ, Chen W, Tsimberidou AM, Manning JT Jr, Medeiros LJ (2006) Myeloid sarcoma involving the gynecologic tract: a report of 11 cases and review of the literature. Am J Clin Pathol 125:783–790PubMedCrossRefPubMedCentralGoogle Scholar
  193. Gard GB, Mulvany NJ, Quinn MA (1999) Management of uterine leiomyosarcoma in Australia. Aust N Z J Obstet Gynaecol 39:93–98PubMedPubMedCentralGoogle Scholar
  194. Gardie B et al (2011) Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet 48:226–234.  https://doi.org/10.1136/jmg.2010.085068CrossRefPubMedPubMedCentralGoogle Scholar
  195. Garg K, Tickoo SK, Soslow RA, Reuter VE (2011) Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report. Am J Surg Pathol 35:1235–1237.  https://doi.org/10.1097/PAS.0b013e318223ca01CrossRefPubMedPubMedCentralGoogle Scholar
  196. Gersell DJ, Fulling KH (1989) Localized neurofibromatosis of the female genitourinary tract. Am J Surg Pathol 13:873–878PubMedCrossRefPubMedCentralGoogle Scholar
  197. Geyer JT, Ferry JA, Harris NL, Young RH, Longtine JA, Zukerberg LR (2010) Florid reactive lymphoid hyperplasia of the lower female genital tract (lymphoma-like lesion): a benign condition that frequently harbors clonal immunoglobulin heavy chain gene rearrangements. Am J Surg Pathol 34:161–168.  https://doi.org/10.1097/PAS.0b013e3181cc4f12CrossRefPubMedPubMedCentralGoogle Scholar
  198. Gil-Benso R, Lopez-Gines C, Navarro S, Carda C, Llombart-Bosch A (1999) Endometrial stromal sarcomas: immunohistochemical, electron microscopical and cytogenetic findings in two cases. Virchows Arch 434:307–314PubMedCrossRefPubMedCentralGoogle Scholar
  199. Gilks CB, Taylor GP, Clement PB (1987) Inflammatory pseudotumor of the uterus. Int J Gynecol Pathol 6:275–286PubMedCrossRefPubMedCentralGoogle Scholar
  200. Gilks CB, Young RH, Clement PB, Hart WR, Scully RE (1996) Adenomyomas of the uterine cervix of of endocervical type: a report of ten cases of a benign cervical tumor that may be confused with adenoma malignum [corrected]. Mod Pathol 9:220–224PubMedPubMedCentralGoogle Scholar
  201. Gilks CB, Clement PB, Hart WR, Young RH (2000) Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type: a clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief consideration of adenomyomas of other female genital tract sites. Int J Gynecol Pathol 19:195–205PubMedCrossRefPubMedCentralGoogle Scholar
  202. Giner F, Compan A, Monteagudo C (2012) Uterine glomeruloid hemangioma in a patient without POEMS syndrome. Int J Surg Pathol 20:407–410.  https://doi.org/10.1177/1066896911429297CrossRefPubMedPubMedCentralGoogle Scholar
  203. Gisser SD, Young I (1977) Neurilemoma-like uterine myomas: an ultrastructural reaffirmation of their non-Schwannian nature. Am J Obstet Gynecol 129:389–392PubMedCrossRefPubMedCentralGoogle Scholar
  204. Giuntoli RL 2nd, Bristow RE (2004) Uterine leiomyosarcoma: present management. Curr Opin Oncol 16:324–327PubMedCrossRefPubMedCentralGoogle Scholar
  205. Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS (2003) Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 89:460–469PubMedCrossRefPubMedCentralGoogle Scholar
  206. Giuntoli RL 2nd, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL (2007) Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med 52:1001–1010PubMedPubMedCentralGoogle Scholar
  207. Goldberg MF, Hurt WG, Frable WJ (1977) Leiomyomatosis peritonealis disseminata. Report of a case and review of the literature. Obstet Gynecol 49:46–52PubMedPubMedCentralGoogle Scholar
  208. Goldblum JR, Clement PB, Hart WR (1995) Adenomyosis with sparse glands: a potential mimic of low-grade endometrial stromal sarcoma. Am J Clin Pathol 103:218–223PubMedCrossRefPubMedCentralGoogle Scholar
  209. Gomez-Laencina AM, Martinez Diaz F, Izquierdo Sanjuanes B, Vicente Sanchez EM, Fernandez Salmeron R, Meseguer Pena F (2012) Localized neurofibromatosis of the female genital system: a case report and review of the literature. J Obstet Gynaecol Res 38:953–956.  https://doi.org/10.1111/j.1447-0756.2011.01816.xCrossRefPubMedPubMedCentralGoogle Scholar
  210. Goncharova EA et al (2002) Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem 277:30958–30967.  https://doi.org/10.1074/jbc.M202678200CrossRefPubMedPubMedCentralGoogle Scholar
  211. Goode B et al (2018) Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation. Mod Pathol 31:660–673.  https://doi.org/10.1038/modpathol.2017.153CrossRefPubMedPubMedCentralGoogle Scholar
  212. Gordts S, Grimbizis G, Campo R (2018) Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril 109:380–388.e381.  https://doi.org/10.1016/j.fertnstert.2018.01.006CrossRefPubMedPubMedCentralGoogle Scholar
  213. Gown AM, Boyd HC, Chang Y, Ferguson M, Reichler B, Tippens D (1988) Smooth muscle cells can express cytokeratins of “simple” epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. Am J Pathol 132:223–232PubMedPubMedCentralGoogle Scholar
  214. Grayson W, Fourie J, Tiltman AJ (1998) Xanthomatous leiomyosarcoma of the uterine cervix. Int J Gynecol Pathol 17:89–90PubMedCrossRefPubMedCentralGoogle Scholar
  215. Greene LA, Mount SL, Schned AR, Cooper K (2003) Recurrent perivascular epithelioid cell tumor of the uterus (PEComa): an immunohistochemical study and review of the literature. Gynecol Oncol 90:677–681PubMedCrossRefPubMedCentralGoogle Scholar
  216. Gremel G et al (2015) A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival. Int J Cancer 136:1608–1618.  https://doi.org/10.1002/ijc.29141CrossRefPubMedPubMedCentralGoogle Scholar
  217. Grignon DJ, Carey MR, Kirk ME, Robinson ML (1987) Diffuse uterine leiomyomatosis: a case study with pregnancy complicated by intrapartum hemorrhage. Obstet Gynecol 69:477–480PubMedPubMedCentralGoogle Scholar
  218. Gross KL et al (2004) Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies. Genes Chromosomes Cancer 41:183–190.  https://doi.org/10.1002/gcc.20079CrossRefPubMedPubMedCentralGoogle Scholar
  219. Gunnala V et al (2017) Novel fumarate hydratase mutation in siblings with early onset uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer syndrome. Int J Gynecol Pathol.  https://doi.org/10.1097/pgp.0000000000000423PubMedCrossRefPubMedCentralGoogle Scholar
  220. Guntupalli SR, Ramirez PT, Anderson ML, Milam MR, Bodurka DC, Malpica A (2009) Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol 113:324–326.  https://doi.org/10.1016/j.ygyno.2009.02.020CrossRefPubMedPubMedCentralGoogle Scholar
  221. Guo X et al (2015) Clinically relevant molecular subtypes in leiomyosarcoma. Clin Cancer Res 21:3501–3511.  https://doi.org/10.1158/1078-0432.ccr-14-3141CrossRefPubMedPubMedCentralGoogle Scholar
  222. Gyure KA, Hart WR, Kennedy AW (1995) Lymphangiomyomatosis of the uterus associated with tuberous sclerosis and malignant neoplasia of the female genital tract: a report of two cases. Int J Gynecol Pathol 14:344–351PubMedCrossRefPubMedCentralGoogle Scholar
  223. Haimes JD et al (2017) Uterine inflammatory myofibroblastic tumors frequently harbor ALK fusions with IGFBP5 and THBS1. Am J Surg Pathol 41:773–780.  https://doi.org/10.1097/pas.0000000000000801CrossRefPubMedPubMedCentralGoogle Scholar
  224. Halaska MJ, Haidopoulos D, Guyon F, Morice P, Zapardiel I, Kesic V (2017) European Society of gynecological oncology statement on fibroid and uterine morcellation. Int J Gynecol Cancer 27:189–192.  https://doi.org/10.1097/igc.0000000000000911CrossRefPubMedPubMedCentralGoogle Scholar
  225. Halbwedl I et al (2005) Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization. Gynecol Oncol 97:582–587.  https://doi.org/10.1016/j.ygyno.2005.01.002. S0090-8258(05)00022-3 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  226. Hales HA, Peterson CM, Jones KP, Quinn JD (1992) Leiomyomatosis peritonealis disseminata treated with a gonadotropin-releasing hormone agonist. A case report. Am J Obstet Gynecol 167:515–516PubMedCrossRefPubMedCentralGoogle Scholar
  227. Hall KL et al (1997) Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol 65:330–335.  https://doi.org/10.1006/gyno.1997.4653CrossRefPubMedPubMedCentralGoogle Scholar
  228. Hall T, Lee SI, Boruta DM, Goodman A (2015) Medical device safety and surgical dissemination of unrecognized uterine malignancy: morcellation in minimally invasive gynecologic surgery. Oncologist 20:1274–1282.  https://doi.org/10.1634/theoncologist.2015-0061CrossRefPubMedPubMedCentralGoogle Scholar
  229. Han HS, Park IA, Kim SH, Lee HP (1998) The clear cell variant of epithelioid intravenous leiomyomatosis of the uterus: report of a case. Pathol Int 48:892–896PubMedCrossRefPubMedCentralGoogle Scholar
  230. Harris NL, Scully RE (1984) Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases. Cancer 53:2530–2545PubMedCrossRefPubMedCentralGoogle Scholar
  231. Hart WR, Yoonessi M (1977) Endometrial stromatosis of the uterus. Obstet Gynecol 49:393–403PubMedPubMedCentralGoogle Scholar
  232. Hattab EM, Allam-Nandyala P, Rhatigan RM (1999) The stromal component of large endometrial polyps. Int J Gynecol Pathol 18:332–337PubMedCrossRefPubMedCentralGoogle Scholar
  233. Hayashi T et al (2011) Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients. Am J Surg Pathol 35:1776–1785.  https://doi.org/10.1097/PAS.0b013e318235edbdCrossRefPubMedPubMedCentralGoogle Scholar
  234. Heatley MK (2006) Atypical polypoid adenomyoma: a systematic review of the English literature. Histopathology 48:609–610PubMedCrossRefPubMedCentralGoogle Scholar
  235. Heerema-McKenney A et al (2008) Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype. Am J Surg Pathol 32:1513–1522PubMedCrossRefPubMedCentralGoogle Scholar
  236. Hemming ML, Wagner AJ, Nucci MR, Chiang S, Wang L, Hensley ML, George S (2017) YWHAE-rearranged high-grade endometrial stromal sarcoma: two-center case series and response to chemotherapy. Gynecol Oncol 145:531–535.  https://doi.org/10.1016/j.ygyno.2017.03.021. S0090-8258(17)30237-8 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  237. Hendrickson MR, Tavassoli F, Kempson RL, McCluggage G, Hailer U, Kubik-Huch RA (2003) Mesenchymal tumours and related lesions. In: Tavassoli F, Devilee P (eds) World Health Organization classification of tumours. Pathology and genetics of tumors of breast and female genital organs. IARC Press, Lyon, pp 233–244Google Scholar
  238. Hennig Y, Caselitz J, Bartnitzke S, Bullerdiek J (1997) A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14 approximately 21;q11.2 approximately 21). Cancer Genet Cytogenet 98:84–86PubMedCrossRefPubMedCentralGoogle Scholar
  239. Hensley ML (2017) Difficult choices in stage I uterine leiomyosarcoma- it’s okay to “stand there”. Gynecol Oncol 147:1–2.  https://doi.org/10.1016/j.ygyno.2017.09.004CrossRefPubMedPubMedCentralGoogle Scholar
  240. Hensley ML et al (2002) Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20:2824–2831.  https://doi.org/10.1200/jco.2002.11.050CrossRefPubMedPubMedCentralGoogle Scholar
  241. Hensley ML, Blessing JA, DeGeest K, Abulafia O, Rose PG, Homesley HD (2008a) Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecol Oncol 109:323–328.  https://doi.org/10.1016/j.ygyno.2008.02.024CrossRefPubMedPubMedCentralGoogle Scholar
  242. Hensley ML, Blessing JA, Mannel R, Rose PG (2008b) Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol 109:329–334.  https://doi.org/10.1016/j.ygyno.2008.03.010CrossRefPubMedPubMedCentralGoogle Scholar
  243. Hillard JB, Malpica A, Ramirez PT (2004) Conservative management of a uterine tumor resembling an ovarian sex cord-stromal tumor. Gynecol Oncol 92:347–352PubMedCrossRefPubMedCentralGoogle Scholar
  244. Hilsenbeck SG, Allred DC (1992) Improved methods of estimating mitotic activity in solid tumors. Hum Pathol 23:601–602PubMedCrossRefPubMedCentralGoogle Scholar
  245. Hirschfield L, Kahn LB, Chen S, Winkler B, Rosenberg S (1986) Mullerian adenosarcoma with ovarian sex cord-like differentiation. A light- and electron-microscopic study. Cancer 57:1197–1200PubMedCrossRefPubMedCentralGoogle Scholar
  246. Hirschowitz L, Mayall FG, Ganesan R, McCluggage WG (2013) Intravascular adenomyomatosis: expanding the morphologic spectrum of intravascular leiomyomatosis. Am J Surg Pathol 37:1395–1400.  https://doi.org/10.1097/PAS.0b013e31828b2c99. 00000478-201309000-00013 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  247. Hoang LN et al (2017) Novel high-grade endometrial stromal sarcoma: a morphologic mimicker of myxoid leiomyosarcoma. Am J Surg Pathol 41:12–24.  https://doi.org/10.1097/pas.0000000000000721CrossRefPubMedPubMedCentralGoogle Scholar
  248. Hoang L, Chiang S, Lee CH (2018) Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 50:162–177.  https://doi.org/10.1016/j.pathol.2017.11.086. S0031-3025(17)30393-8 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  249. Hodgson A, Amemiya Y, Seth A, Djordjevic B, Parra-Herran C (2017) High-grade mullerian adenosarcoma: genomic and clinicopathologic characterization of a distinct neoplasm with prevalent TP53 pathway alterations and aggressive behavior. Am J Surg Pathol 41:1513–1522.  https://doi.org/10.1097/pas.0000000000000907CrossRefPubMedPubMedCentralGoogle Scholar
  250. Holzmann C, Markowski DN, Bartnitzke S, Koczan D, Helmke BM, Bullerdiek J (2015) A rare coincidence of different types of driver mutations among uterine leiomyomas (UL). Mol Cytogenet 8:76.  https://doi.org/10.1186/s13039-015-0177-9CrossRefPubMedPubMedCentralGoogle Scholar
  251. Horie Y, Ikawa S, Kadowaki K, Minagawa Y, Kigawa J, Terakawa N (1995) Lipoadenofibroma of the uterine corpus: report of a new variant of adenofibroma (benign mÅllerian mixed tumor). Arch Pathol Lab Med 119:274–276PubMedPubMedCentralGoogle Scholar
  252. Hornick JL, Fletcher CD (2008) Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum. Am J Surg Pathol 32:493–501.  https://doi.org/10.1097/PAS.0b013e318161dc34CrossRefPubMedPubMedCentralGoogle Scholar
  253. Horstmann JP, Pietra GG, Harman JA, Cole NG, Grinspan S (1977) Spontaneous regression of pulmonary leiomyomas during pregnancy. Cancer 39:314–321PubMedCrossRefPubMedCentralGoogle Scholar
  254. Houghton JP, McCluggage WG (2007) Embryonal rhabdomyosarcoma of the cervix with focal pleomorphic areas. J Clin Pathol 60:88–89PubMedPubMedCentralCrossRefGoogle Scholar
  255. Howitt BE, Quade BJ, Nucci MR (2015a) Uterine polyps with features overlapping with those of mullerian adenosarcoma: a clinicopathologic analysis of 29 cases emphasizing their likely benign nature. Am J Surg Pathol 39:116–126.  https://doi.org/10.1097/pas.0000000000000303CrossRefPubMedPubMedCentralGoogle Scholar
  256. Howitt BE et al (2015b) Targeted genomic analysis of mullerian adenosarcoma. J Pathol 235:37–49.  https://doi.org/10.1002/path.4442CrossRefPubMedPubMedCentralGoogle Scholar
  257. Howitt BE, Dal Cin P, Nucci MR, Quade BJ (2016) Involvement of chromosome 8 in mullerian adenosarcoma. Int J Gynecol Pathol.  https://doi.org/10.1097/PGP.0000000000000287PubMedCrossRefPubMedCentralGoogle Scholar
  258. Hrzenjak A (2016) JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas. Orphanet J Rare Dis 11:15.  https://doi.org/10.1186/s13023-016-0400-8CrossRefPubMedPubMedCentralGoogle Scholar
  259. Huang HY, Ladanyi M, Soslow RA (2004) Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity. Am J Surg Pathol 28:224–232PubMedCrossRefPubMedCentralGoogle Scholar
  260. Hung YP, Fletcher CD, Hornick JL (2016) Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma. Mod Pathol 29:370–380.  https://doi.org/10.1038/modpathol.2016.31CrossRefPubMedPubMedCentralGoogle Scholar
  261. Hurrell DP, McCluggage WG (2005) Uterine leiomyosarcoma with HMB45+ clear cell areas: report of two cases. Histopathology 47:540–542PubMedCrossRefPubMedCentralGoogle Scholar
  262. Hurrell DP, McCluggage WG (2007) Uterine tumour resembling ovarian sex cord tumour is an immunohistochemically polyphenotypic neoplasm which exhibits coexpression of epithelial, myoid and sex cord markers. J Clin Pathol 60:1148–1154.  https://doi.org/10.1136/jcp.2006.044842CrossRefPubMedPubMedCentralGoogle Scholar
  263. Hyde KE, Geisinger KR, Marshall RB, Jones TL (1989) The clear-cell variant of uterine epithelioid leiomyoma. An immunohistologic and ultrastructural study. Arch Pathol Lab Med 113:551–553PubMedPubMedCentralGoogle Scholar
  264. Hyman DM, Grisham RN, Hensley ML (2014) Management of advanced uterine leiomyosarcoma. Curr Opin Oncol 26:422–427.  https://doi.org/10.1097/cco.0000000000000094CrossRefPubMedPubMedCentralGoogle Scholar
  265. Iasonos A et al (2013) External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma. Cancer 119:1816–1822.  https://doi.org/10.1002/cncr.27971CrossRefPubMedPubMedCentralGoogle Scholar
  266. Ip PP, Cheung AN, Clement PB (2009) Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases. Am J Surg Pathol 33:992–1005.  https://doi.org/10.1097/PAS.0b013e3181a02d1cCrossRefPubMedPubMedCentralGoogle Scholar
  267. Irving JA, Carinelli S, Prat J (2006) Uterine tumors resembling ovarian sex cord tumors are polyphenotypic neoplasms with true sex cord differentiation. Mod Pathol 19:17–24.  https://doi.org/10.1038/modpathol.3800475CrossRefPubMedPubMedCentralGoogle Scholar
  268. Ito H, Sasaki N, Miyagawa K, Tahara E (1986) Bizarre leiomyoblastoma of the cervix uteri. Immunohistochemical and ultrastructural study. Acta Pathol Jpn 36:1737–1745PubMedPubMedCentralGoogle Scholar
  269. Jabbour MN, Seoud M, Al-Ahmadie H, Abdul-Karim FW, Zaatari GS (2014) ASPL-TFE3 translocation in vulvovaginal alveolar soft part sarcoma. Int J Gynecol Pathol 33:263–267.  https://doi.org/10.1097/PGP.0b013e318290407cCrossRefPubMedPubMedCentralGoogle Scholar
  270. Jakate K et al (2013) Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors. Mod Pathol 26:95–105.  https://doi.org/10.1038/modpathol.2012.136CrossRefPubMedPubMedCentralGoogle Scholar
  271. Jautzke G, Muller-Ruchholtz E, Thalmann U (1996) Immunohistological detection of estrogen and progesterone receptors in multiple and well differentiated leiomyomatous lung tumors in women with uterine leiomyomas (so-called benign metastasizing leiomyomas). A report on 5 cases. Pathol Res Pract 192:215–223.  https://doi.org/10.1016/s0344-0338(96)80224-xCrossRefPubMedPubMedCentralGoogle Scholar
  272. Jones MW, Lefkowitz M (1995) Adenosarcoma of the uterine cervix: a clinicopathological study of 12 cases. Int J Gynecol Pathol 14:223–229PubMedCrossRefPubMedCentralGoogle Scholar
  273. Jones MW, Norris HJ (1995) Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol 14:243–249PubMedCrossRefPubMedCentralGoogle Scholar
  274. Joseph NM, Solomon DA, Frizzell N, Rabban JT, Zaloudek C, Garg K (2015) Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients. Am J Surg Pathol 39:1529–1539.  https://doi.org/10.1097/pas.0000000000000520CrossRefPubMedPubMedCentralGoogle Scholar
  275. Jung CK, Jung JH, Lee A, Lee YS, Choi YJ, Yoon SK, Lee KY (2008) Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors. Mod Pathol 21:756–763.  https://doi.org/10.1038/modpathol.2008.53CrossRefPubMedPubMedCentralGoogle Scholar
  276. Kaku T, Silverberg SG, Major FJ, Miller A, Fetter B, Brady MF (1992) Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases. Int J Gynecol Pathol 11:75–88PubMedCrossRefPubMedCentralGoogle Scholar
  277. Kaminski PF, Tavassoli FA (1984) Plexiform tumorlet: a clinical and pathologic study of 15 cases with ultrastructural observations. Int J Gynecol Pathol 3:124–134PubMedCrossRefPubMedCentralGoogle Scholar
  278. Karpathiou G, Dal P, Chauleur C, Peoc’h M (2018) Intravascular lymphocytic accumulation in the uterine cervix: a frequent finding. Int J Gynecol Pathol 37:229–232.  https://doi.org/10.1097/pgp.0000000000000407CrossRefPubMedPubMedCentralGoogle Scholar
  279. Kasashima S, Kobayashi M, Yamada M, Oda Y (2003) Myxoid endometrial stromal sarcoma of the uterus. Pathol Int 53:637–641. 1525 [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  280. Kasashima S, Minato H, Kobayashi M, Ueda Y, Oda Y, Hashimoto S, Inoue M (2007) Alveolar soft part sarcoma of the endometrium with expression of CD10 and hormone receptors. APMIS 115:861–865.  https://doi.org/10.1111/j.1600-0463.2007.apm_635.xCrossRefPubMedPubMedCentralGoogle Scholar
  281. Kawaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogaki H, Mori T (1989) Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol 160:637–641PubMedCrossRefPubMedCentralGoogle Scholar
  282. Keel SB, Clement PB, Prat J, Young RH (1998) Malignant schwannoma of the uterine cervix: a study of three cases. Int J Gynecol Pathol 17:223–230PubMedCrossRefPubMedCentralGoogle Scholar
  283. Kempson RL, Hendrickson MR (2000) Smooth muscle, endometrial stromal, and mixed mullerian tumors of the uterus. Mod Pathol 13:328–342.  https://doi.org/10.1038/modpathol.3880055CrossRefPubMedPubMedCentralGoogle Scholar
  284. Kenny SL, McCluggage WG (2014) Adenomyomatous polyp of the endometrium with prominent epithelioid smooth muscle differentiation: report of two cases of a hitherto undescribed lesion. Int J Surg Pathol 22:358–363.  https://doi.org/10.1177/1066896913499630CrossRefPubMedPubMedCentralGoogle Scholar
  285. Kho KA, Lin K, Hechanova M, Richardson DL (2016) Risk of occult uterine sarcoma in women undergoing hysterectomy for benign indications. Obstet Gynecol 127:468–473.  https://doi.org/10.1097/aog.0000000000001242CrossRefPubMedPubMedCentralGoogle Scholar
  286. Kibar Y, Aydin A, Deniz H, Balat O, Cebesoy B, Al-Nafussi A (2008) A rare case of low-grade endometrial stromal sarcoma with myxoid differentiation and atypical bizarre cells. Eur J Gynaecol Oncol 29:397–398PubMedPubMedCentralGoogle Scholar
  287. Kim YH, Cho H, Kyeom-Kim H, Kim I (1996) Uterine endometrial stromal sarcoma with rhabdoid and smooth muscle differentiation. J Korean Med Sci 11:88–93PubMedPubMedCentralCrossRefGoogle Scholar
  288. Kim HS, Yoon G, Jung YY, Lee YY, Song SY (2015) Fibromyxoid variant of endometrial stromal sarcoma with atypical bizarre nuclei. Int J Clin Exp Pathol 8:3316–3321PubMedPubMedCentralGoogle Scholar
  289. King ME, Dickersin GR, Scully RE (1982) Myxoid leiomyosarcoma of the uterus. A report of six cases. Am J Surg Pathol 6:589–598PubMedCrossRefPubMedCentralGoogle Scholar
  290. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM (1996) Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 41:483–490PubMedPubMedCentralGoogle Scholar
  291. Koike N, Tsunemi T, Uekuri C, Akasaka J, Ito F, Shigemitsu A, Kobayashi H (2013) Pathogenesis and malignant transformation of adenomyosis (review). Oncol Rep 29:861–867.  https://doi.org/10.3892/or.2012.2184CrossRefPubMedPubMedCentralGoogle Scholar
  292. Koivisto-Korander R, Butzow R, Koivisto A, Leminen A (2008) Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990–2001. Gynecol Oncol 111:74–81PubMedCrossRefPubMedCentralGoogle Scholar
  293. Kokawa K, Yamoto M, Yata C, Mabuchi Y, Umesaki N (2002) Postmenopausal intravenous leiomyomatosis with high levels of estradiol and estrogen receptor. Obstet Gynecol 100:1124–1126PubMedPubMedCentralGoogle Scholar
  294. Kolin DL et al (2018) SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. Mod Pathol.  https://doi.org/10.1038/s41379-018-0049-zPubMedCrossRefPubMedCentralGoogle Scholar
  295. Koontz JI et al (2001) Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A 98:6348–6353.  https://doi.org/10.1073/pnas.101132598. 98/11/6348. [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  296. Kosari F, Daneshbod Y, Parwaresch R, Krams M, Wacker HH (2005) Lymphomas of the female genital tract: a study of 186 cases and review of the literature. Am J Surg Pathol 29:1512–1520PubMedCrossRefPubMedCentralGoogle Scholar
  297. Koshiyama M et al (2002) Adenocarcinomas arising from uterine adenomyosis: a report of four cases. Int J Gynecol Pathol 21:239–245PubMedCrossRefPubMedCentralGoogle Scholar
  298. Kriseman ML, Wang WL, Sullinger J, Schmeler KM, Ramirez PT, Herzog CE, Frumovitz M (2012) Rhabdomyosarcoma of the cervix in adult women and younger patients. Gynecol Oncol 126:351–356.  https://doi.org/10.1016/j.ygyno.2012.05.008CrossRefPubMedPubMedCentralGoogle Scholar
  299. Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS (2001) Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Gynecol Oncol 83:89–94PubMedCrossRefPubMedCentralGoogle Scholar
  300. Kruse AJ, Croce S, Kruitwagen RF, Riedl RG, Slangen BF, Van Gorp T, Van de Vijver KK (2014a) Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset. Int J Gynecol Cancer 24:1616–1622.  https://doi.org/10.1097/IGC.0000000000000278PubMedCrossRefPubMedCentralGoogle Scholar
  301. Kruse AJ, Sep S, Slangen BF, Vandevijver NM, Van Gorp T, Kruitwagen RF, Van de Vijver KK (2014b) Angiosarcomas of primary gynecologic origin: a clinicopathologic review and quantitative analysis of survival. Int J Gynecol Cancer 24:4–12.  https://doi.org/10.1097/igc.0000000000000020PubMedCrossRefPubMedCentralGoogle Scholar
  302. Kunzel KE, Mills NZ, Muderspach LI, d’Ablaing G 3rd (1993) Myxoid leiomyosarcoma of the uterus. Gynecol Oncol 48:277–280.  https://doi.org/10.1006/gyno.1993.1048CrossRefPubMedPubMedCentralGoogle Scholar
  303. Kurihara S et al (2008) Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases. Am J Surg Pathol 32:1228–1238.  https://doi.org/10.1097/PAS.0b013e31816a3b42CrossRefPubMedPubMedCentralGoogle Scholar
  304. Kurihara S, Oda Y, Ohishi Y, Kaneki E, Kobayashi H, Wake N, Tsuneyoshi M (2010) Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas. Mod Pathol 23:225–234.  https://doi.org/10.1038/modpathol.2009.162CrossRefPubMedPubMedCentralGoogle Scholar
  305. Kurman RJ, Norris HJ (1976) Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear-cell leiomyoma: a clinical and pathologic analysis of 26 cases. Cancer 37:1853–1865PubMedCrossRefPubMedCentralGoogle Scholar
  306. Kurman RJ, Carcangiu ML, Herrington CS, Young RH (2014) WHO classification of tumours of female reproductive organs. World Health Organization classification of tumours, 4th edn. IARC Press, LyonGoogle Scholar
  307. Ladanyi M et al (2001) The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20:48–57.  https://doi.org/10.1038/sj.onc.1204074CrossRefPubMedPubMedCentralGoogle Scholar
  308. Lai FM, Wong FW, Allen PW (1991) Diffuse uterine leiomyomatosis with hemorrhage. Arch Pathol Lab Med 115:834–837PubMedPubMedCentralGoogle Scholar
  309. Lakhman Y et al (2017) Differentiation of uterine leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis. Eur Radiol 27:2903–2915.  https://doi.org/10.1007/s00330-016-4623-9CrossRefPubMedPubMedCentralGoogle Scholar
  310. Langlois PL (1970) The size of the normal uterus. J Reprod Med 4:220–228PubMedPubMedCentralGoogle Scholar
  311. Larson B, Silfversward C, Nilsson B, Pettersson F (1990) Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936–1981. Acta Oncol 29:185–191PubMedCrossRefPubMedCentralGoogle Scholar
  312. Launonen V et al (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 98:3387–3392.  https://doi.org/10.1073/pnas.051633798CrossRefPubMedPubMedCentralGoogle Scholar
  313. Layfield LJ, Liu K, Dodge R, Barsky SH (2000) Uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology. Arch Pathol Lab Med 124:221–227.  https://doi.org/10.1043/0003-9985(2000)124<0221:usmt>2.0.co;2CrossRefPubMedPubMedCentralGoogle Scholar
  314. Leath CA 3rd et al (2007) A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol 105:630–634.  https://doi.org/10.1016/j.ygyno.2007.01.031. S0090-8258(07)00056-X [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  315. Lee HJ, Choi J, Kim KR (2008) Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory. Int J Gynecol Pathol 27:340–345.  https://doi.org/10.1097/PGP.0b013e3181656dabCrossRefPubMedPubMedCentralGoogle Scholar
  316. Lee CH, Turbin DA, Sung YC, Espinosa I, Montgomery K, van de Rijn M, Gilks CB (2009) A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors. Mod Pathol 22:1519–1531.  https://doi.org/10.1038/modpathol.2009.122PubMedCrossRefPubMedCentralGoogle Scholar
  317. Lee CH et al (2012a) Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol 36:1562–1570.  https://doi.org/10.1097/PAS.0b013e31825fa931. 00000478-201210000-00018 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  318. Lee CH et al (2012b) The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol 36:641–653.  https://doi.org/10.1097/PAS.0b013e31824a7b1aCrossRefPubMedPubMedCentralGoogle Scholar
  319. Lee CH et al (2012c) 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci U S A 109:929–934.  https://doi.org/10.1073/pnas.1115528109CrossRefPubMedPubMedCentralGoogle Scholar
  320. Lee CH et al (2014) Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement. Mod Pathol 27:751–757.  https://doi.org/10.1038/modpathol.2013.199CrossRefPubMedPubMedCentralGoogle Scholar
  321. Lee JC et al (2016) Genomewide copy number analysis of mullerian adenosarcoma identified chromosomal instability in the aggressive subgroup. Mod Pathol 29:1070–1082.  https://doi.org/10.1038/modpathol.2016.99CrossRefPubMedPubMedCentralGoogle Scholar
  322. Lehtonen R et al (2004) Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol 164:17–22.  https://doi.org/10.1016/s0002-9440(10)63091-xCrossRefPubMedPubMedCentralGoogle Scholar
  323. Lehtonen HJ et al (2006) Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 43:523–526.  https://doi.org/10.1136/jmg.2005.036400CrossRefPubMedPubMedCentralGoogle Scholar
  324. Leibsohn S, d’Ablaing G, Mishell DR Jr, Schlaerth JB (1990) Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 162:968–974; discussion 974-966PubMedCrossRefPubMedCentralGoogle Scholar
  325. Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS, Soslow RA (2006) Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol 101:86–91.  https://doi.org/10.1016/j.ygyno.2005.09.055CrossRefPubMedPubMedCentralGoogle Scholar
  326. Leitao MM Jr et al (2012) Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma. Gynecol Oncol 124:558–562.  https://doi.org/10.1016/j.ygyno.2011.11.009CrossRefPubMedPubMedCentralGoogle Scholar
  327. Leitao MM, Sonoda Y, Brennan MF, Barakat RR, Chi DS (2003) Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol 91:209–212PubMedCrossRefPubMedCentralGoogle Scholar
  328. Leitao MM et al (2004) Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101:1455–1462.  https://doi.org/10.1002/cncr.20521CrossRefPubMedPubMedCentralGoogle Scholar
  329. Lewis N et al (2017) ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod Pathol.  https://doi.org/10.1038/modpathol.2017.162PubMedCrossRefPubMedCentralGoogle Scholar
  330. Lewis N et al (2018) ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod Pathol 31:674–684.  https://doi.org/10.1038/modpathol.2017.162CrossRefPubMedPubMedCentralGoogle Scholar
  331. Li N, Wu LY, Zhang HT, An JS, Li XG, Ma SK (2008) Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. Gynecol Oncol 108:306–311.  https://doi.org/10.1016/j.ygyno.2007.10.023. S0090-8258(07)00863-3 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  332. Li RF, Gupta M, McCluggage WG, Ronnett BM (2013) Embryonal rhabdomyosarcoma (botryoid type) of the uterine corpus and cervix in adult women: report of a case series and review of the literature. Am J Surg Pathol 37:344–355.  https://doi.org/10.1097/PAS.0b013e31826e0271CrossRefPubMedPubMedCentralGoogle Scholar
  333. Liang SX, Patel K, Pearl M, Liu J, Zheng W, Tornos C (2007) Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review. Int J Gynecol Pathol 26:291–297.  https://doi.org/10.1097/01.pgp.0000236948.67087.56. 00004347-200707000-00017 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  334. Lifschitz-Mercer B, Czernobilsky B, Dgani R, Dallenbach-Hellweg G, Moll R, Franke WW (1987) Immunocytochemical study of an endometrial diffuse clear cell stromal sarcoma and other endometrial stromal sarcomas. Cancer 59:1494–1499PubMedCrossRefPubMedCentralGoogle Scholar
  335. Lillemoe TJ, Perrone T, Norris HJ, Dehner LP (1991) Myogenous phenotype of epithelial-like areas in endometrial stromal sarcomas. Arch Pathol Lab Med 115:215–219PubMedPubMedCentralGoogle Scholar
  336. Lim D, Alvarez T, Nucci MR, Gilks B, Longacre T, Soslow RA, Oliva E (2013) Interobserver variability in the interpretation of tumor cell necrosis in uterine leiomyosarcoma. Am J Surg Pathol 37:650–658.  https://doi.org/10.1097/PAS.0b013e3182851162CrossRefPubMedPubMedCentralGoogle Scholar
  337. Littell RD et al (2017) Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: trends and survival outcomes. Gynecol Oncol 147:11–17.  https://doi.org/10.1016/j.ygyno.2017.07.122CrossRefPubMedPubMedCentralGoogle Scholar
  338. Liu Y, Guo S, Wang L, Suzuki S, Sugimura H, Li Y (2016) Uterine angiosarcoma: a case report and literature review. Int J Gynecol Pathol 35:264–268.  https://doi.org/10.1097/pgp.0000000000000219CrossRefPubMedPubMedCentralGoogle Scholar
  339. Lloreta J, Prat J (1992) Endometrial stromal nodule with smooth and skeletal muscle components simulating stromal sarcoma. Int J Gynecol Pathol 11:293–298PubMedCrossRefPubMedCentralGoogle Scholar
  340. Lloreta J, Prat J (1993) Ultrastructure of an endometrial stromal nodule with skeletal muscle. Ultrastruct Pathol 17:405–410PubMedCrossRefPubMedCentralGoogle Scholar
  341. Lobel MK, Somasundaram P, Morton CC (2006) The genetic heterogeneity of uterine leiomyomata. Obstet Gynecol Clin N Am 33:13–39.  https://doi.org/10.1016/j.ogc.2005.12.006CrossRefGoogle Scholar
  342. Loddenkemper C, Mechsner S, Foss HD, Dallenbach FE, Anagnostopoulos I, Ebert AD, Stein H (2003) Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Am J Surg Pathol 27:1458–1462PubMedCrossRefPubMedCentralGoogle Scholar
  343. Longacre TA, Chung MH, Rouse RV, Hendrickson MR (1996) Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus – a clinicopathologic study of 55 cases. Am J Surg Pathol 20:1–20PubMedCrossRefPubMedCentralGoogle Scholar
  344. Longacre TA, Hendrickson MR, Kempson RL (1997) Predicting clinical outcome for uterine smooth muscle neoplasms with a reasonable degree of certainty. Adv Anat Pathol 4:95–104CrossRefGoogle Scholar
  345. Lotgering FK, Pijpers L, van Eijck J, Wallenburg HC (1989) Pregnancy in a patient with diffuse cavernous hemangioma of the uterus. Am J Obstet Gynecol 160:628–630PubMedCrossRefPubMedCentralGoogle Scholar
  346. Ly A, Mills AM, McKenney JK, Balzer BL, Kempson RL, Hendrickson MR, Longacre TA (2013) Atypical leiomyomas of the uterus: a clinicopathologic study of 51 cases. Am J Surg Pathol 37:643–649.  https://doi.org/10.1097/PAS.0b013e3182893f36CrossRefPubMedPubMedCentralGoogle Scholar
  347. Ma J, Shi QL, Zhou XJ, Meng K, Chen JY, Huang WB (2007) Lymphoma-like lesion of the uterine cervix: report of 12 cases of a rare entity. Int J Gynecol Pathol 26:194–198PubMedCrossRefPubMedCentralGoogle Scholar
  348. Machida H, Nathenson MJ, Takiuchi T, Adams CL, Garcia-Sayre J, Matsuo K (2017) Significance of lymph node metastasis on survival of women with uterine adenosarcoma. Gynecol Oncol 144:524–530.  https://doi.org/10.1016/j.ygyno.2017.01.012CrossRefPubMedPubMedCentralGoogle Scholar
  349. Majmudar B, Ghanee N, Horowitz IR, Graham D (1998) Uterine arteriovenous malformation necessitating hysterectomy with bilateral salpingo-oophorectomy in a young pregnant patient. Arch Pathol Lab Med 122:842–845PubMedPubMedCentralGoogle Scholar
  350. Major FJ et al (1993) Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71:1702–1709PubMedCrossRefPubMedCentralGoogle Scholar
  351. Makinen N et al (2016) Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12. PLoS Genet 12:e1005850.  https://doi.org/10.1371/journal.pgen.1005850CrossRefPubMedPubMedCentralGoogle Scholar
  352. Malpica A, Deavers MT, Silva EG (2006) High grade sarcoma in endometrial stromal sarcoma: dedifferentiated endometrial stromal sarcoma [Abstract]. Modern Pathol 19:188AGoogle Scholar
  353. Maluf HM, Gersell DJ (1994) Uterine leiomyomas with high content of mast cells. Arch Pathol Lab Med 118:712–714PubMedPubMedCentralGoogle Scholar
  354. Mansi JL, Ramachandra S, Wiltshaw E, Fisher C (1990) Endometrial stromal sarcomas. Gynecol Oncol 36:113–118PubMedCrossRefPubMedCentralGoogle Scholar
  355. Marino-Enriquez A et al (2018) BCOR internal tandem duplication in high-grade uterine sarcomas. Am J Surg Pathol 42:335–341.  https://doi.org/10.1097/pas.0000000000000993CrossRefPubMedPubMedCentralGoogle Scholar
  356. Markowski DN, Bartnitzke S, Loning T, Drieschner N, Helmke BM, Bullerdiek J (2012) MED12 mutations in uterine fibroids – their relationship to cytogenetic subgroups. Int J Cancer 131:1528–1536.  https://doi.org/10.1002/ijc.27424CrossRefPubMedPubMedCentralGoogle Scholar
  357. Markowski DN, Holzmann C, Bullerdiek J (2015) Genetic alterations in uterine fibroids – a new direction for pharmacological intervention? Expert Opin Ther Targets 19:1485–1494.  https://doi.org/10.1517/14728222.2015.1075510CrossRefPubMedPubMedCentralGoogle Scholar
  358. Marsh EE, Bulun SE (2006) Steroid hormones and leiomyomas. Obstet Gynecol Clin N Am 33:59–67.  https://doi.org/10.1016/j.ogc.2005.12.001CrossRefGoogle Scholar
  359. Marshall RJ, Braye SG, Jones DB (1986) Leiomyosarcoma of the uterus with giant cells resembling osteoclasts. Int J Gynecol Pathol 5:260–268PubMedCrossRefPubMedCentralGoogle Scholar
  360. Marshburn PB, Matthews ML, Hurst BS (2006) Uterine artery embolization as a treatment option for uterine myomas. Obstet Gynecol Clin N Am 33:125–144.  https://doi.org/10.1016/j.ogc.2005.12.009CrossRefGoogle Scholar
  361. Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F (2008) PEComas: the past, the present and the future. Virchows Arch 452:119–132.  https://doi.org/10.1007/s00428-007-0509-1CrossRefPubMedPubMedCentralGoogle Scholar
  362. Martin KA, Rzucidlo EM, Merenick BL, Fingar DC, Brown DJ, Wagner RJ, Powell RJ (2004) The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol 286:C507–C517.  https://doi.org/10.1152/ajpcell.00201.2003CrossRefPubMedPubMedCentralGoogle Scholar
  363. Martin-Reay DG, Christ ML, LaPata RE (1991) Uterine leiomyoma with skeletal muscle differentiation. Report of a case. Am J Clin Pathol 96:344–347PubMedCrossRefPubMedCentralGoogle Scholar
  364. Matsubara A et al (2013) Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours. Histopathology 62:657–661.  https://doi.org/10.1111/his.12039CrossRefPubMedPubMedCentralGoogle Scholar
  365. Mayerhofer K et al (1999) Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 74:196–201.  https://doi.org/10.1006/gyno.1999.5436CrossRefPubMedPubMedCentralGoogle Scholar
  366. Mazur MT, Kraus FT (1980) Histogenesis of morphologic variations in tumors of the uterine wall. Am J Surg Pathol 4:59–74PubMedCrossRefPubMedCentralGoogle Scholar
  367. Mazur MT, Priest JB (1986) Clear cell leiomyoma (leiomyoblastoma) of the uterus: ultrastructural observations. Ultrastruct Pathol 10:249–255PubMedCrossRefPubMedCentralGoogle Scholar
  368. McCluggage WG (2010) Mullerian adenosarcoma of the female genital tract. Adv Anat Pathol 17:122–129.  https://doi.org/10.1097/PAP.0b013e3181cfe732CrossRefPubMedPubMedCentralGoogle Scholar
  369. McCluggage WG (2016) A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus. Mod Pathol 29(Suppl 1):S78–S91.  https://doi.org/10.1038/modpathol.2015.137CrossRefPubMedPubMedCentralGoogle Scholar
  370. McCluggage WG, Young RH (2008) Endometrial stromal sarcomas with true papillae and pseudopapillae. Int J Gynecol Pathol 27:555–561.  https://doi.org/10.1097/PGP.0b013e31817a82f9CrossRefPubMedPubMedCentralGoogle Scholar
  371. McCluggage WG, Date A, Bharucha H, Toner PG (1996) Endometrial stromal sarcoma with sex cord-like areas and focal rhabdoid differentiation. Histopathology 29:369–374PubMedCrossRefPubMedCentralGoogle Scholar
  372. McCluggage WG, Alderdice JM, Walsh MY (1999) Polypoid uterine lesions mimicking endometrial stromal sarcoma. J Clin Pathol 52:543–546PubMedPubMedCentralCrossRefGoogle Scholar
  373. McCluggage WG, Ellis PK, McClure N, Walker WJ, Jackson PA, Manek S (2000) Pathologic features of uterine leiomyomas following uterine artery embolization. Int J Gynecol Pathol 19:342–347PubMedCrossRefPubMedCentralGoogle Scholar
  374. McCluggage WG, Cromie AJ, Bryson C, Traub AI (2001a) Uterine endometrial stromal sarcoma with smooth muscle and glandular differentiation. J Clin Pathol 54:481–483PubMedPubMedCentralCrossRefGoogle Scholar
  375. McCluggage WG, Sumathi VP, Maxwell P (2001b) CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 39:273–278PubMedCrossRefPubMedCentralGoogle Scholar
  376. McCluggage WG, Ganesan R, Herrington CS (2009) Endometrial stromal sarcomas with extensive endometrioid glandular differentiation: report of a series with emphasis on the potential for misdiagnosis and discussion of the differential diagnosis. Histopathology 54:365–373.  https://doi.org/10.1111/j.1365-2559.2009.03230.x. HIS3230 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  377. McDonald AG, Dal Cin P, Ganguly A, Campbell S, Imai Y, Rosenberg AE, Oliva E (2011) Liposarcoma arising in uterine lipoleiomyoma: a report of 3 cases and review of the literature. Am J Surg Pathol 35:221–227.  https://doi.org/10.1097/PAS.0b013e31820414f7CrossRefPubMedPubMedCentralGoogle Scholar
  378. Meenakshi M, McCluggage WG (2010) Vascular involvement in adenomyosis: report of a large series of a common phenomenon with observations on the pathogenesis of adenomyosis. Int J Gynecol Pathol 29:117–121.  https://doi.org/10.1097/PGP.0b013e3181b7018d. 00004347-201003000-00004 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  379. Mehine M et al (2013) Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 369:43–53.  https://doi.org/10.1056/NEJMoa1302736CrossRefPubMedPubMedCentralGoogle Scholar
  380. Mehine M, Makinen N, Heinonen HR, Aaltonen LA, Vahteristo P (2014) Genomics of uterine leiomyomas: insights from high-throughput sequencing. Fertil Steril 102:621–629.  https://doi.org/10.1016/j.fertnstert.2014.06.050CrossRefPubMedPubMedCentralGoogle Scholar
  381. Mentrikoski M, Lastra R, Kurman RJ (2015) Mullerian adenosarcomas with rhabdomyoblastic differentiation are associated with an aggressive clinical course. Mod Pathol 28:298AGoogle Scholar
  382. Meredith RF, Eisert DR, Kaka Z, Hodgson SE, Johnston GA Jr, Boutselis JG (1986) An excess of uterine sarcomas after pelvic irradiation. Cancer 58:2003–2007PubMedCrossRefPubMedCentralGoogle Scholar
  383. Merino MJ, Torres-Cabala C, Pinto P, Linehan WM (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31:1578–1585.  https://doi.org/10.1097/PAS.0b013e31804375b8CrossRefPubMedPubMedCentralGoogle Scholar
  384. Micci F, Walter CU, Teixeira MR, Panagopoulos I, Bjerkehagen B, Saeter G, Heim S (2003) Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17). Cancer Genet Cytogenet 144:119–124. S0165460803000256 [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  385. Micci F, Panagopoulos I, Bjerkehagen B, Heim S (2006) Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res 66:107–112.  https://doi.org/10.1158/0008-5472.CAN-05-2485. 66/1/107 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  386. Micci F, Gorunova L, Gatius S, Matias-Guiu X, Davidson B, Heim S, Panagopoulos I (2014) MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma. Cancer Lett 347:75–78.  https://doi.org/10.1016/j.canlet.2014.01.030CrossRefPubMedPubMedCentralGoogle Scholar
  387. Micci F et al (2016) Cytogenetic and molecular profile of endometrial stromal sarcoma. Genes Chromosomes Cancer 55:834–846.  https://doi.org/10.1002/gcc.22380CrossRefPubMedPubMedCentralGoogle Scholar
  388. Micci F, Brunetti M, Dal Cin P, Nucci MR, Gorunova L, Heim S, Panagopoulos I (2017) Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma. Genes Chromosomes Cancer 56:841–845.  https://doi.org/10.1002/gcc.22485CrossRefPubMedPubMedCentralGoogle Scholar
  389. Miettinen M, Lasota J (2011) Histopathology of gastrointestinal stromal tumor. J Surg Oncol 104:865–873.  https://doi.org/10.1002/jso.21945CrossRefPubMedPubMedCentralGoogle Scholar
  390. Miettinen M, Felisiak-Golabek A, Wasag B, Chmara M, Wang Z, Butzow R, Lasota J (2016) Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases. Am J Surg Pathol 40:1661–1669.  https://doi.org/10.1097/pas.0000000000000703CrossRefPubMedPubMedCentralGoogle Scholar
  391. Mikami Y, Hata S, Kiyokawa T, Manabe T (2002) Expression of CD10 in malignant mullerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod Pathol 15:923–930.  https://doi.org/10.1097/01.MP.0000026058.33869.DBCrossRefPubMedPubMedCentralGoogle Scholar
  392. Miller KN, McClure SP (1992) Papillary adenofibroma of the uterus: report of a case involved by adenocarcinoma and review of the literature. Am J Clin Pathol 97:806–809PubMedCrossRefPubMedCentralGoogle Scholar
  393. Mills AM, Karamchandani JR, Vogel H, Longacre TA (2011) Endocervical fibroblastic malignant peripheral nerve sheath tumor (neurofibrosarcoma): report of a novel entity possibly related to endocervical CD34 fibrocytes. Am J Surg Pathol 35:404–412.  https://doi.org/10.1097/PAS.0b013e318208f72e. 00000478-201103000-00011 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  394. Minassian SS, Frangipane W, Polin JI, Ellis M (1986) Leiomyomatosis peritonealis disseminata. A case report and literature review. J Reprod Med 31:997–1000PubMedPubMedCentralGoogle Scholar
  395. Mittal K, Demopoulos RI (2001) MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 32:984–987.  https://doi.org/10.1053/hupa.2001.27113CrossRefPubMedPubMedCentralGoogle Scholar
  396. Mittal K, Joutovsky A (2007) Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas. Gynecol Oncol 104:362–365.  https://doi.org/10.1016/j.ygyno.2006.08.034CrossRefPubMedPubMedCentralGoogle Scholar
  397. Mittal K, Popiolek D, Demopoulos RI (2000) Uterine myxoid leiomyosarcoma within a leiomyoma. Hum Pathol 31:398–400PubMedCrossRefPubMedCentralGoogle Scholar
  398. Mittal KR et al (2009) Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas. Mod Pathol 22:1303–1311.  https://doi.org/10.1038/modpathol.2009.96CrossRefPubMedPubMedCentralGoogle Scholar
  399. Moinfar F, Regitnig P, Tabrizi AD, Denk H, Tavassoli FA (2004) Expression of androgen receptors in benign and malignant endometrial stromal neoplasms. Virchows Arch 444:410–414.  https://doi.org/10.1007/s00428-004-0981-9CrossRefPubMedPubMedCentralGoogle Scholar
  400. Moinfar F, Azodi M, Tavassoli FA (2007) Uterine sarcomas. Pathology 39:55–71.  https://doi.org/10.1080/00313020601136146CrossRefPubMedPubMedCentralGoogle Scholar
  401. Moore M, McCluggage WG (2017) Uterine tumour resembling ovarian sex cord tumour: first report of a large series with follow-up. Histopathology 71:751–759.  https://doi.org/10.1111/his.13296CrossRefPubMedPubMedCentralGoogle Scholar
  402. Morice P et al (2003) Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients. Eur J Gynaecol Oncol 24:237–240PubMedPubMedCentralGoogle Scholar
  403. Morotti RA et al (2006) An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children’s Oncology Group experience. Am J Surg Pathol 30:962–968PubMedCrossRefPubMedCentralGoogle Scholar
  404. Mulvany NJ, Slavin JL, Ostor AG, Fortune DW (1994) Intravenous leiomyomatosis of the uterus: a clinicopathologic study of 22 cases. Int J Gynecol Pathol 13:1–9PubMedCrossRefPubMedCentralGoogle Scholar
  405. Mulvany NJ, Ostor AG, Ross I (1995) Diffuse leiomyomatosis of the uterus. Histopathology 27:175–179PubMedCrossRefPubMedCentralGoogle Scholar
  406. Myles JL, Hart WR (1985) Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage. Am J Surg Pathol 9:798–805PubMedCrossRefPubMedCentralGoogle Scholar
  407. Nakayama H, Teramoto H, Teramoto M (2013) True incidence of uterine adenomatoid tumors. Biomed Rep 1:352–354.  https://doi.org/10.3892/br.2013.72CrossRefPubMedPubMedCentralGoogle Scholar
  408. Nasioudis D, Alevizakos M, Chapman-Davis E, Witkin SS, Holcomb K (2017a) Rhabdomyosarcoma of the lower female genital tract: an analysis of 144 cases. Arch Gynecol Obstet 296:327–334.  https://doi.org/10.1007/s00404-017-4438-1CrossRefPubMedPubMedCentralGoogle Scholar
  409. Nasioudis D, Kampaktsis PN, Frey M, Witkin SS, Holcomb K (2017b) Primary lymphoma of the female genital tract: an analysis of 697 cases. Gynecol Oncol 145:305–309.  https://doi.org/10.1016/j.ygyno.2017.02.043CrossRefPubMedPubMedCentralGoogle Scholar
  410. Navarro D et al (1992) Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness. J Steroid Biochem Mol Biol 41:589–596PubMedCrossRefPubMedCentralGoogle Scholar
  411. Ng TL et al (2005) Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 18:68–74.  https://doi.org/10.1038/modpathol.3800272CrossRefPubMedPubMedCentralGoogle Scholar
  412. Nielsen GP, Oliva E, Young RH, Rosenberg AE, Dickersin GR, Scully RE (1995) Alveolar soft-part sarcoma of the female genital tract: a report of nine cases and review of the literature. Int J Gynecol Pathol 14:283–292PubMedCrossRefPubMedCentralGoogle Scholar
  413. Nogales FF Jr, Matilla A, Carrascal E (1978) Leiomyomatosis peritonealis disseminata. An ultrastructural study. Am J Clin Pathol 69:452–457PubMedCrossRefPubMedCentralGoogle Scholar
  414. Nogales FF et al (1987) Uterine intravascular leiomyomatosis: an update and report of seven cases. Int J Gynecol Pathol 6:331–339PubMedCrossRefPubMedCentralGoogle Scholar
  415. Nogales FF et al (2002) Adenomatoid tumors of the uterus: an analysis of 60 cases. Int J Gynecol Pathol 21:34–40PubMedCrossRefPubMedCentralGoogle Scholar
  416. Nogales FF, Stolnicu S, Harilal KR, Mooney E, Garcia-Galvis OF (2009) Retiform uterine tumours resembling ovarian sex cord tumours. A comparative immunohistochemical study with retiform structures of the female genital tract. Histopathology 54:471–477.  https://doi.org/10.1111/j.1365-2559.2009.03244.x. HIS3244 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  417. Nola M et al (1996) Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer 78:2543–2550PubMedCrossRefPubMedCentralGoogle Scholar
  418. Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Trope CG (1995) The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol 34:797–802PubMedCrossRefPubMedCentralGoogle Scholar
  419. Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Trope CG (1996) The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol 62:254–259.  https://doi.org/10.1006/gyno.1996.0224. S0090-8258(96)90224-3 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  420. Norris HJ, Parmley T (1975) Mesenchymal tumors of the uterus. V. Intravenous leiomyomatosis. A clinical and pathologic study of 14 cases. Cancer 36:2164–2178PubMedCrossRefPubMedCentralGoogle Scholar
  421. Norris HJ, Taylor HB (1966) Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 19:755–766PubMedCrossRefPubMedCentralGoogle Scholar
  422. Norris HJ, Hilliard GD, Irey NS (1988) Hemorrhagic cellular leiomyomas (“apoplectic leiomyoma”) of the uterus associated with pregnancy and oral contraceptives. Int J Gynecol Pathol 7:212–224PubMedCrossRefPubMedCentralGoogle Scholar
  423. Novelli M et al (2010) DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology 57:259–270.  https://doi.org/10.1111/j.1365-2559.2010.03624.x. HIS3624 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  424. Nucci MR (2016) Practical issues related to uterine pathology: endometrial stromal tumors. Mod Pathol 29(Suppl 1):S92–S103.  https://doi.org/10.1038/modpathol.2015.140CrossRefPubMedPubMedCentralGoogle Scholar
  425. Nucci MR, O’Connell JT, Huettner PC, Cviko A, Sun D, Quade BJ (2001) h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 25:455–463PubMedCrossRefPubMedCentralGoogle Scholar
  426. Nucci MR, Harburger D, Koontz J, Dal Cin P, Sklar J (2007) Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol 31:65–70.  https://doi.org/10.1097/01.pas.0000213327.86992.d1. 00000478-200701000-00007 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  427. Nunez-Alonso C, Battifora HA (1979) Plexiform tumors of the uterus: ultrastructural study. Cancer 44:1707–1714PubMedCrossRefPubMedCentralGoogle Scholar
  428. O’Cearbhaill R, Hensley ML (2010) Optimal management of uterine leiomyosarcoma. Expert Rev Anticancer Ther 10:153–169.  https://doi.org/10.1586/era.09.187CrossRefPubMedPubMedCentralGoogle Scholar
  429. O’Connor DM, Norris HJ (1990) Mitotically active leiomyomas of the uterus. Hum Pathol 21:223–227PubMedCrossRefPubMedCentralGoogle Scholar
  430. O’Leary TJ, Steffes MW (1996) Can you count on the mitotic index? Hum Pathol 27:147–151PubMedCrossRefPubMedCentralGoogle Scholar
  431. O’Neill CJ, McBride HA, Connolly LE, McCluggage WG (2007) Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. Histopathology 50:851–858.  https://doi.org/10.1111/j.1365-2559.2007.02699.xCrossRefPubMedPubMedCentralGoogle Scholar
  432. Oduyebo T et al (2014) The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol 132:360–365.  https://doi.org/10.1016/j.ygyno.2013.11.024CrossRefPubMedPubMedCentralGoogle Scholar
  433. Ohta Y, Suzuki T, Omatsu M, Hamatani S, Shiokawa A, Kushima M, Ota H (2010) Transition from low-grade endometrial stromal sarcoma to high-grade endometrial stromal sarcoma. Int J Gynecol Pathol 29:374–377.  https://doi.org/10.1097/PGP.0b013e3181cef14b. 00004347-201007000-00013 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  434. Oliva E (2014) Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations. Int J Gynecol Pathol 33:374–384.  https://doi.org/10.1097/PGP.0000000000000141CrossRefPubMedPubMedCentralGoogle Scholar
  435. Oliva E (2016) Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia. Mod Pathol 29(Suppl 1):S104–S120.  https://doi.org/10.1038/modpathol.2015.139CrossRefPubMedPubMedCentralGoogle Scholar
  436. Oliva E, Young RH, Clement PB, Bhan AK, Scully RE (1995) Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 19:757–768PubMedCrossRefPubMedCentralGoogle Scholar
  437. Oliva E, Ferry JA, Young RH, Prat J, Srigley JR, Scully RE (1997) Granulocytic sarcoma of the female genital tract: a clinicopathologic study of 11 cases. Am J Surg Pathol 21:1156–1165PubMedCrossRefPubMedCentralGoogle Scholar
  438. Oliva E, Clement PB, Young RH, Scully RE (1998) Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases. Am J Surg Pathol 22:997–1005PubMedCrossRefPubMedCentralGoogle Scholar
  439. Oliva E, Young RH, Clement PB, Scully RE (1999) Myxoid and fibrous endometrial stromal tumors of the uterus: a report of 10 cases. Int J Gynecol Pathol 18:310–319PubMedCrossRefPubMedCentralGoogle Scholar
  440. Oliva E, Clement PB, Young RH (2000) Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 7:257–281PubMedCrossRefPubMedCentralGoogle Scholar
  441. Oliva E, Clement PB, Young RH (2002a) Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors. Int J Gynecol Pathol 21:48–55PubMedCrossRefPubMedCentralGoogle Scholar
  442. Oliva E, Young RH, Amin MB, Clement PB (2002b) An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26:403–412PubMedCrossRefPubMedCentralGoogle Scholar
  443. Oliva EW, Wang WL, Branton P, Logani S, Zannoni GF, Linkov I, Asher M, Soslow RA (2006) Expression of melanocytic (“PEComa”) markers in smooth muscle tumors of the uterus: an immunohistochemcial analyisis of 86 cases. Paper presented at the United States and Canadian Academy of Pathology, AtlantaGoogle Scholar
  444. Oliva E, de Leval L, Soslow RA, Herens C (2007) High frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal tumors with smooth muscle differentiation by interphase FISH detection. Am J Surg Pathol 31:1277–1284.  https://doi.org/10.1097/PAS.0b013e318031f012PubMedCrossRefPubMedCentralGoogle Scholar
  445. Oliva E, Carinelli SG, Carcangiu ML (2014) Mesenchymal tumours. Chapter 5, Tumours of the uterine corpus. In: Kurman R, Carcangiu ML, Herrington CS, Young RH (eds) WHO classification of tumours of female reproductive organs. IARC Press, Lyon, pp 135–145Google Scholar
  446. Ordi J, Stamatakos MD, Tavassoli FA (1997) Pure pleomorphic rhabdomyosarcomas of the uterus. Int J Gynecol Pathol 16:369–377PubMedCrossRefPubMedCentralGoogle Scholar
  447. Orii A, Mori A, Zhai YL, Toki T, Nikaido T, Fujii S (1998) Mast cells in smooth muscle tumors of the uterus. Int J Gynecol Pathol 17:336–342PubMedCrossRefPubMedCentralGoogle Scholar
  448. Ouyang DW, Economy KE, Norwitz ER (2006) Obstetric complications of fibroids. Obstet Gynecol Clin N Am 33:153–169.  https://doi.org/10.1016/j.ogc.2005.12.010CrossRefGoogle Scholar
  449. Panagopoulos I et al (2012) Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma. PLoS One 7:e39354.  https://doi.org/10.1371/journal.pone.0039354. PONE-D-12-09483 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  450. Panagopoulos I et al (2013) Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation. Genes Chromosomes Cancer 52:610–618.  https://doi.org/10.1002/gcc.22057CrossRefPubMedPubMedCentralGoogle Scholar
  451. Park SH, Ro JY, Kim HS, Lee ES (2003) Perivascular epithelioid cell tumor of the uterus: immunohistochemical, ultrastructural and molecular study. Pathol Int 53:800–805PubMedCrossRefPubMedCentralGoogle Scholar
  452. Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH (2008) Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989–2007. J Cancer Res Clin Oncol 134:1277–1287.  https://doi.org/10.1007/s00432-008-0422-2CrossRefPubMedPubMedCentralGoogle Scholar
  453. Park JY, Park SK, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH (2011) The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol 122:255–259.  https://doi.org/10.1016/j.ygyno.2011.04.021CrossRefPubMedPubMedCentralGoogle Scholar
  454. Park JY, Sung CO, Jang SJ, Song SY, Han JH, Kim KR (2013) Pulmonary metastatic nodules of uterine low-grade endometrial stromal sarcoma: histopathological and immunohistochemical analysis of 10 cases. Histopathology 63:833–840.  https://doi.org/10.1111/his.12232CrossRefPubMedPubMedCentralGoogle Scholar
  455. Parker WH, Fu YS, Berek JS (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83:414–418PubMedPubMedCentralGoogle Scholar
  456. Parker WH, Kaunitz AM, Pritts EA, Olive DL, Chalas E, Clarke-Pearson DL, Berek JS (2016) U.S. Food and Drug Administration’s guidance regarding morcellation of leiomyomas: well-intentioned, but is it harmful for women? Obstet Gynecol 127:18–22.  https://doi.org/10.1097/aog.0000000000001157CrossRefPubMedPubMedCentralGoogle Scholar
  457. Parra-Herran CE, Yuan L, Nucci MR, Quade BJ (2014) Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics: the IFITM1 model. Mod Pathol 27:569–579.  https://doi.org/10.1038/modpathol.2013.123CrossRefPubMedPubMedCentralGoogle Scholar
  458. Parra-Herran C, Quick CM, Howitt BE, Dal Cin P, Quade BJ, Nucci MR (2015) Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course. Am J Surg Pathol 39:157–168.  https://doi.org/10.1097/pas.0000000000000330CrossRefPubMedPubMedCentralGoogle Scholar
  459. Parra-Herran C, Schoolmeester JK, Yuan L, Dal Cin P, Fletcher CD, Quade BJ, Nucci MR (2016) Myxoid leiomyosarcoma of the uterus: a clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms. Am J Surg Pathol 40:285–301.  https://doi.org/10.1097/PAS.0000000000000593. 00000478-201603000-00001 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  460. Patai K, Illyes G, Varbiro S, Gidai J, Kosa L, Vajo Z (2006) Uterine leiomyosarcoma with osteoclast like giant cells and long standing systemic symptoms. Gynecol Oncol 102:403–405.  https://doi.org/10.1016/j.ygyno.2006.02.030CrossRefPubMedPubMedCentralGoogle Scholar
  461. Pautier P et al (2000) Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88:1425–1431PubMedCrossRefPubMedCentralGoogle Scholar
  462. Pauwels P, Dal Cin P, Van de Moosdijk CN, Vrints L, Sciot R, Van den Berghe H (1996) Cytogenetics revealing the diagnosis in a metastatic endometrial stromal sarcoma. Histopathology 29:84–87Google Scholar
  463. Payson M, Leppert P, Segars J (2006) Epidemiology of myomas. Obstet Gynecol Clin N Am 33:1–11.  https://doi.org/10.1016/j.ogc.2005.12.004CrossRefGoogle Scholar
  464. Pedeutour F, Quade BJ, Sornberger K, Tallini G, Ligon AH, Weremowicz S, Morton CC (2000) Dysregulation of HMGIC in a uterine lipoleiomyoma with a complex rearrangement including chromosomes 7, 12, and 14. Genes Chromosomes Cancer 27:209–215PubMedCrossRefPubMedCentralGoogle Scholar
  465. Pelmus M et al (2009) Prognostic factors in early-stage leiomyosarcoma of the uterus. Int J Gynecol Cancer 19:385–390.  https://doi.org/10.1111/IGC.0b013e3181a1bfbcCrossRefPubMedPubMedCentralGoogle Scholar
  466. Pérot G et al (2012) MED12 alterations in both human benign and malignant uterine soft tissue tumors. PLoS One 7:e40015.  https://doi.org/10.1371/journal.pone.0040015CrossRefPubMedPubMedCentralGoogle Scholar
  467. Perrone T, Dehner LP (1988) Prognostically favorable “mitotically active” smooth-muscle tumors of the uterus. A clinicopathologic study of ten cases. Am J Surg Pathol 12:1–8PubMedCrossRefPubMedCentralGoogle Scholar
  468. Peters WA 3rd, Howard DR, Andersen WA, Figge DC (1994) Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol 83:1015–1020PubMedCrossRefPubMedCentralGoogle Scholar
  469. Pickett JL et al (2017) Inflammatory myofibroblastic tumors of the female genital tract are under-recognized: a low threshold for ALK immunohistochemistry is required. Am J Surg Pathol 41:1433–1442.  https://doi.org/10.1097/pas.0000000000000909CrossRefPubMedPubMedCentralGoogle Scholar
  470. Pieslor PC, Orenstein JM, Hogan DL, Breslow A (1979) Ultrastructure of myofibroblasts and decidualized cells in leiomyomatosis peritonealis disseminata. Am J Clin Pathol 72:875–882PubMedCrossRefPubMedCentralGoogle Scholar
  471. Pinto A, Kahn RM, Rosenberg AE, Slomovitz B, Quick CM, Whisman MK, Huang M (2018) Uterine rhabdomyosarcoma in adults. Hum Pathol.  https://doi.org/10.1016/j.humpath.2018.01.007PubMedCrossRefPubMedCentralGoogle Scholar
  472. Piscuoglio S et al (2016) Uterine adenosarcomas are mesenchymal neoplasms. J Pathol 238:381–388.  https://doi.org/10.1002/path.4675CrossRefPubMedPubMedCentralGoogle Scholar
  473. Portugal R, Oliva E (2009) Calretinin: diagnostic utility in the female genital tract. Adv Anat Pathol 16:118–124.  https://doi.org/10.1097/PAP.0b013e31819923ce. 00125480-200903000-00005 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  474. Pounder DJ (1982) Fatty tumours of the uterus. J Clin Pathol 35:1380–1383PubMedPubMedCentralCrossRefGoogle Scholar
  475. Pradhan D, Mohanty SK (2013) Uterine tumors resembling ovarian sex cord tumors. Arch Pathol Lab Med 137:1832–1836.  https://doi.org/10.5858/arpa.2012-0634-RSCrossRefPubMedPubMedCentralGoogle Scholar
  476. Prat J (2009) FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 104:177–178.  https://doi.org/10.1016/j.ijgo.2008.12.008CrossRefPubMedPubMedCentralGoogle Scholar
  477. Prat J, Mbatani (2015) Uterine sarcomas. Int J Gynaecol Obstet 131(Suppl 2):S105–S110.  https://doi.org/10.1016/j.ijgo.2015.06.006. S0020-7292(15)00377-X [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  478. Prayson RA, Hart WR (1992) Mitotically active leiomyomas of the uterus. Am J Clin Pathol 97:14–20PubMedCrossRefPubMedCentralGoogle Scholar
  479. Prayson RA, Goldblum JR, Hart WR (1997) Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients. Am J Surg Pathol 21:383–391PubMedCrossRefPubMedCentralGoogle Scholar
  480. Press MF, Scully RE (1985) Endometrial “sarcomas” complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy. Gynecol Oncol 21:135–154. 0090-8258(85)90246-X [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  481. Pugh A, McCluggage WG, Hirschowitz L (2012) Multifocal uterine myxoid change: a newly recognized association with neurofibromatosis type 1. Int J Gynecol Pathol 31:580–583.  https://doi.org/10.1097/PGP.0b013e31824d359aCrossRefPubMedPubMedCentralGoogle Scholar
  482. Punnett HH, Halligan GE, Zaeri N, Karmazin N (1989) Translocation 10;17 in clear cell sarcoma of the kidney. A first report. Cancer Genet Cytogenet 41:123–128. 0165-4608(89)90116-7 [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  483. Quade BJ (1995) Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions. Curr Opin Obstet Gynecol 7:35–42PubMedCrossRefPubMedCentralGoogle Scholar
  484. Quade BJ, McLachlin CM, Soto-Wright V, Zuckerman J, Mutter GL, Morton CC (1997) Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation. Am J Pathol 150:2153–2166PubMedPubMedCentralGoogle Scholar
  485. Quade BJ, Dal Cin P, Neskey DM, Weremowicz S, Morton CC (2002) Intravenous leiomyomatosis: molecular and cytogenetic analysis of a case. Mod Pathol 15:351–356.  https://doi.org/10.1038/modpathol.3880529CrossRefPubMedPubMedCentralGoogle Scholar
  486. Quade BJ, Weremowicz S, Neskey DM, Vanni R, Ladd C, Dal Cin P, Morton CC (2003) Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res 63:1351–1358PubMedPubMedCentralGoogle Scholar
  487. Quddus MR, Rashid L, Sung CJ, Steinhoff MM, Cunxian Z, Lawrence WD (2009) Ewing’s sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) differentiation in endometrial serous carcinomas. Reprod Sci 16:591–595.  https://doi.org/10.1177/1933719109332824CrossRefPubMedPubMedCentralGoogle Scholar
  488. Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA (2005) Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol 29:1348–1355PubMedCrossRefPubMedCentralGoogle Scholar
  489. Rackow BW, Arici A (2006) Options for medical treatment of myomas. Obstet Gynecol Clin N Am 33:97–113.  https://doi.org/10.1016/j.ogc.2005.12.014CrossRefGoogle Scholar
  490. Radig K, Buhtz P, Roessner A (1998) Alveolar soft part sarcoma of the uterine corpus. Report of two cases and review of the literature. Pathol Res Pract 194:59–63PubMedCrossRefPubMedCentralGoogle Scholar
  491. Rahimi S, Akaev I, Marani C, Chopra M, Yeoh CC (2018) Immunohistochemical expression of different subtypes of cytokeratins by endometrial stromal sarcoma. Appl Immunohistochem Mol Morphol.  https://doi.org/10.1097/PAI.0000000000000642
  492. Rakheja D, Weinberg AG, Tomlinson GE, Partridge K, Schneider NR (2004) Translocation (10;17)(q22;p13): a recurring translocation in clear cell sarcoma of kidney. Cancer Genet Cytogenet 154:175–179.  https://doi.org/10.1016/j.cancergencyto.2004.02.024. S0165-4608(04)00111-6 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  493. Ramalingam P, Masand RP, Euscher ED, Malpica A (2016) Undifferentiated carcinoma of the endometrium: an expanded immunohistochemical analysis including PAX-8 and basal-like carcinoma surrogate markers. Int J Gynecol Pathol 35:410–418.  https://doi.org/10.1097/PGP.0000000000000248CrossRefPubMedPubMedCentralGoogle Scholar
  494. Rao Q et al (2013) Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas. Histopathology 62:642–650.  https://doi.org/10.1111/his.12059CrossRefPubMedPubMedCentralGoogle Scholar
  495. Raut CP et al (2009) Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma. Eur J Cancer 45:2818–2824.  https://doi.org/10.1016/j.ejca.2009.06.030CrossRefPubMedPubMedCentralGoogle Scholar
  496. Ravid Y, Formanski M, Smith Y, Reich R, Davidson B (2016) Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures. Gynecol Oncol 140:512–517.  https://doi.org/10.1016/j.ygyno.2016.01.001CrossRefPubMedPubMedCentralGoogle Scholar
  497. Reed NS et al (2008) Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 44:808–818.  https://doi.org/10.1016/j.ejca.2008.01.019CrossRefPubMedPubMedCentralGoogle Scholar
  498. Regidor PA, Schmidt M, Callies R, Kato K, Schindler AE (1995) Estrogen and progesterone receptor content of GnRH analogue pretreated and untreated uterine leiomyomata. Eur J Obstet Gynecol Reprod Biol 63:69–73PubMedCrossRefPubMedCentralGoogle Scholar
  499. Reich O, Regauer S (2004) Aromatase expression in low-grade endometrial stromal sarcomas: an immunohistochemical study. Mod Pathol 17:104–108.  https://doi.org/10.1038/sj.modpathol.3800031CrossRefPubMedPubMedCentralGoogle Scholar
  500. Reich O, Regauer S (2007) Hormonal therapy of endometrial stromal sarcoma. Curr Opin Oncol 19:347–352.  https://doi.org/10.1097/CCO.0b013e3281a7ef3a. 00001622-200707000-00011 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  501. Reich O, Regauer S, Urdl W, Lahousen M, Winter R (2000) Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 82:1030–1034.  https://doi.org/10.1054/bjoc.1999.1038. S0007092099910388 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  502. Reyes C, Karamurzin Y, Frizzell N, Garg K, Nonaka D, Chen YB, Soslow RA (2014) Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry. Mod Pathol 27:1020–1027.  https://doi.org/10.1038/modpathol.2013.215CrossRefPubMedPubMedCentralGoogle Scholar
  503. Rivasi F, Botticelli L, Bettelli SR, Masellis G (2008) Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues. Int J Gynecol Pathol 27:442–446PubMedCrossRefPubMedCentralGoogle Scholar
  504. Rizeq MN, van de Rijn M, Hendrickson MR, Rouse RV (1994) A comparative immunohistochemical study of uterine smooth muscle neoplasms with emphasis on the epithelioid variant. Hum Pathol 25:671–677PubMedCrossRefPubMedCentralGoogle Scholar
  505. Roma AA, Yang B, Senior ME, Goldblum JR (2005) TFE3 immunoreactivity in alveolar soft part sarcoma of the uterine cervix: case report. Int J Gynecol Pathol 24:131–135PubMedCrossRefPubMedCentralGoogle Scholar
  506. Roma AA, Allende D, Fadare O, Forscher C, Rutgers JK (2017) On uterine angiosarcomas: 2 additional cases. Int J Gynecol Pathol 36:369–371.  https://doi.org/10.1097/pgp.0000000000000352CrossRefPubMedPubMedCentralGoogle Scholar
  507. Ronaghy A, Xiao GQ, Santagada E, Hasanovic A, Unger P (2018) Expression of GATA-3 in testicular and gynecologic mesothelial neoplastic and non-neoplastic tissues. Int J Gynecol Pathol 37:284–289.  https://doi.org/10.1097/pgp.0000000000000403CrossRefPubMedPubMedCentralGoogle Scholar
  508. Rose PG, Piver MS, Tsukada Y, Lau T (1989) Patterns of metastasis in uterine sarcoma. An autopsy study. Cancer 63:935–938PubMedCrossRefPubMedCentralGoogle Scholar
  509. Rosty C, Genestie C, Blondon J, Le Charpentier Y (1998) Endometrial stromal tumor associated with rhabdoid phenotype and and zones of “sex cord-like” differentiation. Ann Pathol 18:133–136. MDOI-AP-07-1998-18-2-0242-6498-101019-ART57 [pii]Google Scholar
  510. Roth LM, Reed RJ (1999) Dissecting leiomyomas of the uterus other than cotyledonoid dissecting leiomyomas: a report of eight cases. Am J Surg Pathol 23:1032–1039PubMedCrossRefPubMedCentralGoogle Scholar
  511. Roth LM, Reed RJ (2000) Cotyledonoid leiomyoma of the uterus: report of a case. Int J Gynecol Pathol 19:272–275PubMedCrossRefPubMedCentralGoogle Scholar
  512. Roth E, Taylor HB (1966) Heterotopic cartilage in the uterus. Obstet Gynecol 27:838–844PubMedPubMedCentralGoogle Scholar
  513. Roth LM, Reed RJ, Sternberg WH (1996) Cotyledonoid dissecting leiomyoma of the uterus. The Sternberg tumor. Am J Surg Pathol 20:1455–1461PubMedCrossRefPubMedCentralGoogle Scholar
  514. Roy M et al (2017) Androgen receptor expression in endometrial stromal sarcoma: correlation with clinicopathologic features. Int J Gynecol Pathol 36:420–427.  https://doi.org/10.1097/PGP.0000000000000353CrossRefPubMedPubMedCentralGoogle Scholar
  515. Rush DS, Tan J, Baergen RN, Soslow RA (2001) h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25:253–258PubMedCrossRefPubMedCentralGoogle Scholar
  516. Rushing RS et al (2003) Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT. Gynecol Oncol 91:9–14PubMedCrossRefPubMedCentralGoogle Scholar
  517. Sahin AA, Silva EG, Landon G, Ordonez NG, Gershenson DM (1989) Endometrial tissue in myometrial vessels not associated with menstruation. Int J Gynecol Pathol 8:139–146PubMedCrossRefPubMedCentralGoogle Scholar
  518. Sangoi AR, McKenney JK, Schwartz EJ, Rouse RV, Longacre TA (2009) Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases. Mod Pathol 22:1228–1235.  https://doi.org/10.1038/modpathol.2009.90CrossRefPubMedPubMedCentralGoogle Scholar
  519. Sanz-Ortega J, Vocke C, Stratton P, Linehan WM, Merino MJ (2013) Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol 37:74–80.  https://doi.org/10.1097/PAS.0b013e31825ec16fCrossRefPubMedPubMedCentralGoogle Scholar
  520. Satoh Y, Ishikawa Y, Miyoshi T, Mukai H, Okumura S, Nakagawa K (2003) Pulmonary metastases from a low-grade endometrial stromal sarcoma confirmed by chromosome aberration and fluorescence in-situ hybridization approaches: a case of recurrence 13 years after hysterectomy. Virchows Arch 442:173–178.  https://doi.org/10.1007/s00428-002-0731-9CrossRefPubMedPubMedCentralGoogle Scholar
  521. Schaefer IM, Hornick JL, Sholl LM, Quade BJ, Nucci MR, Parra-Herran C (2017) Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour. Histopathology 70:1138–1146.  https://doi.org/10.1111/his.13176CrossRefPubMedPubMedCentralGoogle Scholar
  522. Schammel DP, Tavassoli FA (1998) Uterine angiosarcomas: a morphologic and immunohistochemical study of four cases. Am J Surg Pathol 22:246–250PubMedCrossRefPubMedCentralGoogle Scholar
  523. Schammel DP, Silver SA, Tavassoli FA (1999) Combined endometrial stromal/smooth muscle neoplasms of the uterus. A clinicopathologic study of 38 cases [abstract]. Mod Pathol 12:124AGoogle Scholar
  524. Schmid C, Beham A, Kratochvil P (1990) Haematopoiesis in a degenerating uterine leiomyoma. Arch Gynecol Obstet 248:81–86PubMedCrossRefPubMedCentralGoogle Scholar
  525. Schneider D, Halperin R, Segal M, Maymon R, Bukovsky I (1995) Myxoid leiomyosarcoma of the uterus with unusual malignant histologic pattern – a case report. Gynecol Oncol 59:156–158.  https://doi.org/10.1006/gyno.1995.1284CrossRefPubMedPubMedCentralGoogle Scholar
  526. Schoenmakers EF, Huysmans C, Van de Ven WJ (1999) Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. Cancer Res 59:19–23Google Scholar
  527. Schoenmakers EF et al (2013) Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma. Genes Chromosomes Cancer 52:11–23.  https://doi.org/10.1002/gcc.22001CrossRefPubMedPubMedCentralGoogle Scholar
  528. Schoolmeester JK, Park KJ (2015) Incidental nodal lymphangioleiomyomatosis is not a harbinger of pulmonary lymphangioleiomyomatosis: a study of 19 cases with evaluation of diagnostic immunohistochemistry. Am J Surg Pathol 39:1404–1410.  https://doi.org/10.1097/pas.0000000000000470CrossRefPubMedPubMedCentralGoogle Scholar
  529. Schoolmeester JK, Howitt BE, Hirsch MS, Dal Cin P, Quade BJ, Nucci MR (2014) Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol 38:176–188.  https://doi.org/10.1097/pas.0000000000000133CrossRefPubMedPubMedCentralGoogle Scholar
  530. Schoolmeester JK et al (2015) TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis. Am J Surg Pathol 39:394–404.  https://doi.org/10.1097/pas.0000000000000349CrossRefPubMedPubMedCentralGoogle Scholar
  531. Schoolmeester JK, Stamatakos MD, Moyer AM, Park KJ, Fairbairn M, Fader AN (2016) Pleomorphic Liposarcoma arising in a lipoleiomyosarcoma of the uterus: report of a case with genetic profiling by a next generation sequencing panel. Int J Gynecol Pathol 35:321–326.  https://doi.org/10.1097/pgp.0000000000000241CrossRefPubMedPubMedCentralGoogle Scholar
  532. Schoolmeester JK, Carlson J, Keeney GL, Fritchie KJ, Oliva E, Young RH, Nucci MR (2017) Alveolar soft part sarcoma of the female genital tract: a morphologic, immunohistochemical, and molecular cytogenetic study of 10 cases with emphasis on its distinction from morphologic mimics. Am J Surg Pathol 41:622–632.  https://doi.org/10.1097/pas.0000000000000796CrossRefPubMedPubMedCentralGoogle Scholar
  533. Schwartz PE, Kelly MG (2006) Malignant transformation of myomas: myth or reality? Obstet Gynecol Clin N Am 33:183–198, xii.  https://doi.org/10.1016/j.ogc.2005.12.003PubMedCrossRefPubMedCentralGoogle Scholar
  534. Schwartz LB, Diamond MP, Schwartz PE (1993) Leiomyosarcomas: clinical presentation. Am J Obstet Gynecol 168:180–183PubMedCrossRefPubMedCentralGoogle Scholar
  535. Sciallis AP, Bedroske PP, Schoolmeester JK, Sukov WR, Keeney GL, Hodge JC, Bell DA (2014) High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. Am J Surg Pathol 38:1161–1172.  https://doi.org/10.1097/PAS.0000000000000256. 00000478-201409000-00001 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  536. Seidman JD, Thomas RM (1993) Multiple plexiform tumorlets of the uterus. Arch Pathol Lab Med 117:1255–1256PubMedPubMedCentralGoogle Scholar
  537. Seidman MA, Oduyebo T, Muto MG, Crum CP, Nucci MR, Quade BJ (2012) Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. PLoS One 7:e50058.  https://doi.org/10.1371/journal.pone.0050058CrossRefPubMedPubMedCentralGoogle Scholar
  538. Sener AB, Seckin NC, Ozmen S, Gokmen O, Dogu N, Ekici E (1996) The effects of hormone replacement therapy on uterine fibroids in postmenopausal women. Fertil Steril 65:354–357PubMedCrossRefPubMedCentralGoogle Scholar
  539. Shah R, McCluggage WG (2009) Symplastic atypia in neoplastic and non-neoplastic endometrial stroma: report of 3 cases with a review of atypical symplastic cells within the female genital tract. Int J Gynecol Pathol 28:334–337.  https://doi.org/10.1097/PGP.0b013e3181999450CrossRefPubMedPubMedCentralGoogle Scholar
  540. Shah VI, McCluggage WG (2015) Cyclin D1 does not distinguish YWHAE-NUTM2 high-grade endometrial stromal sarcoma from undifferentiated endometrial carcinoma. Am J Surg Pathol 39:722–724.  https://doi.org/10.1097/PAS.0000000000000427. 00000478-201505000-00019 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  541. Shah JP, Bryant CS, Kumar S, Ali-Fehmi R, Malone JM Jr, Morris RT (2008) Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma. Obstet Gynecol 112:1102–1108.  https://doi.org/10.1097/AOG.0b013e31818aa89a. 112/5/1102 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  542. Shaw RW (1998) Gonadotrophin hormone-releasing hormone analogue treatment of fibroids. Baillieres Clin Obstet Gynaecol 12:245–268PubMedCrossRefPubMedCentralGoogle Scholar
  543. Signorelli M, Fruscio R, Dell’Anna T, Buda A, Giuliani D, Ceppi L, Milani R (2010) Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review. Int J Gynecol Cancer 20:1363–1366.  https://doi.org/10.1111/IGC.0b013e3181efd861. 00009577-201011000-00015 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  544. Silva EG, Tornos C, Ordonez NG, Morris M (1995) Uterine leiomyosarcoma with clear cell areas. Int J Gynecol Pathol 14:174–178PubMedCrossRefPubMedCentralGoogle Scholar
  545. Silva EG, Deavers MT, Bodurka DC, Malpica A (2004) Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol 28:244–249PubMedCrossRefPubMedCentralGoogle Scholar
  546. Silva EG, Bodurka DC, Scouros MA, Ayala A (2005) A uterine leiomyosarcoma that became positive for HMB45 in the metastasis. Ann Diagn Pathol 9:43–45PubMedCrossRefPubMedCentralGoogle Scholar
  547. Simpson KW, Albores-Saavedra J (2007) HMB-45 reactivity in conventional uterine leiomyosarcomas. Am J Surg Pathol 31:95–98.  https://doi.org/10.1097/01.pas.0000213346.57391.70CrossRefPubMedPubMedCentralGoogle Scholar
  548. Sinkre P, Albores-Saavedra J, Miller DS, Copeland LJ, Hameed A (2000a) Endometrial endometrioid carcinomas associated with Ewing sarcoma/peripheral primitive neuroectodermal tumor. Int J Gynecol Pathol 19:127–132PubMedCrossRefPubMedCentralGoogle Scholar
  549. Sinkre P, Miller DS, Milchgrub S, Hameed A (2000b) Adenomyofibroma of the endometrium with skeletal muscle differentiation. Int J Gynecol Pathol 19:280–283PubMedCrossRefPubMedCentralGoogle Scholar
  550. Siskin GP et al (2006) A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. J Vasc Interv Radiol 17:1287–1295.  https://doi.org/10.1097/01.rvi.0000231953.91787.afCrossRefPubMedPubMedCentralGoogle Scholar
  551. Slatter TL et al (2015) Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma. J Pathol Clin Res 1:95–105.  https://doi.org/10.1002/cjp2.11CrossRefPubMedPubMedCentralGoogle Scholar
  552. Sorensen PHB et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol 20:2672–2679PubMedCrossRefPubMedCentralGoogle Scholar
  553. Sornberger KS et al (1999) Expression of HMGIY in three uterine leiomyomata with complex rearrangements of chromosome 6. Cancer Genet Cytogenet 114:9–16PubMedCrossRefPubMedCentralGoogle Scholar
  554. Soslow RA, Ali A, Oliva E (2008) Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases. Am J Surg Pathol 32:1013–1021PubMedCrossRefPubMedCentralGoogle Scholar
  555. Sozen I, Arici A (2006) Cellular biology of myomas: interaction of sex steroids with cytokines and growth factors. Obstet Gynecol Clin N Am 33:41–58.  https://doi.org/10.1016/j.ogc.2005.12.005CrossRefGoogle Scholar
  556. Spies JB, Ascher SA, Roth AR, Kim J, Levy EB, Gomez-Jorge J (2001) Uterine artery embolization for leiomyomata. Obstet Gynecol 98:29–34PubMedPubMedCentralGoogle Scholar
  557. Staats PN et al (2009) Uterine tumors resembling ovarian sex cord tumors (UTROSCT) lack the JAZF1-JJAZ1 translocation frequently seen in endometrial stromal tumors. Am J Surg Pathol 33:1206–1212.  https://doi.org/10.1097/PAS.1200b1013e3181a1207b1209cfCrossRefPubMedPubMedCentralGoogle Scholar
  558. Stemme S, Ghaderi M, Carlson JW (2014) Diagnosis of endometrial stromal tumors: a clinicopathologic study of 25 biopsy specimens with identification of problematic areas. Am J Clin Pathol 141:133–139.  https://doi.org/10.1309/AJCPXD0TPYSNVI8I. 141/1/133 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  559. Stewart L et al (2008) Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Arch Dermatol 144:1584–1592.  https://doi.org/10.1001/archdermatol.2008.517CrossRefPubMedPubMedCentralGoogle Scholar
  560. Stewart CJ, Leung YC, Murch A, Peverall J (2014) Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases. Histopathology 65:473–482.  https://doi.org/10.1111/his.12406CrossRefPubMedPubMedCentralGoogle Scholar
  561. Stewart CJ, Charles A, Foulkes WD (2016a) Gynecologic manifestations of the DICER1 syndrome. Surg Pathol Clin 9:227–241.  https://doi.org/10.1016/j.path.2016.01.002CrossRefPubMedPubMedCentralGoogle Scholar
  562. Stewart CJ, Crook M, Tan A (2016b) SF1 immunohistochemistry is useful in differentiating uterine tumours resembling sex cord-stromal tumours from potential histological mimics. Pathology 48:434–440.  https://doi.org/10.1016/j.pathol.2016.03.013CrossRefPubMedPubMedCentralGoogle Scholar
  563. Stolnicu S, Molnar C, Barsan I, Boros M, Nogales FF, Soslow RA (2016) The impact on survival of an extensive sex cord-like component in mullerian adenosarcomas: a study comprising 6 cases. Int J Gynecol Pathol 35:147–152.  https://doi.org/10.1097/pgp.0000000000000231CrossRefPubMedPubMedCentralGoogle Scholar
  564. Stovall TG, Ling FW, Henry LC, Woodruff MR (1991) A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas. Am J Obstet Gynecol 164:1420–1423; discussion 1423-1425PubMedCrossRefPubMedCentralGoogle Scholar
  565. Subbiah V et al (2015) STUMP un “stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion. J Hematol Oncol 8:66.  https://doi.org/10.1186/s13045-015-0160-2CrossRefPubMedPubMedCentralGoogle Scholar
  566. Suginami H, Kaura R, Ochi H, Matsuura S (1990) Intravenous leiomyomatosis with cardiac extension: successful surgical management and histopathologic study. Obstet Gynecol 76:527–529PubMedPubMedCentralGoogle Scholar
  567. Sullivan LM, Atkins KA, LeGallo RD (2009) PAX immunoreactivity identifies alveolar rhabdomyosarcoma. Am J Surg Pathol 33:775–780.  https://doi.org/10.1097/PAS.0b013e318191614fCrossRefPubMedPubMedCentralGoogle Scholar
  568. Sumathi VP, Al-Hussaini M, Connolly LE, Fullerton L, McCluggage WG (2004) Endometrial stromal neoplasms are immunoreactive with WT-1 antibody. Int J Gynecol Pathol 23:241–247. 00004347-200407000-00007 [pii]PubMedCrossRefPubMedCentralGoogle Scholar
  569. Sutton G, Blessing J, Hanjani P, Kramer P (2005) Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 96:749–752.  https://doi.org/10.1016/j.ygyno.2004.11.036CrossRefPubMedPubMedCentralGoogle Scholar
  570. Tahlan A, Nanda A, Mohan H (2006) Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature. Int J Gynecol Pathol 25:361–365PubMedCrossRefPubMedCentralGoogle Scholar
  571. Tai LH, Tavassoli FA (2002) Endometrial polyps with atypical (bizarre) stromal cells. Am J Surg Pathol 26:505–509PubMedCrossRefPubMedCentralGoogle Scholar
  572. Tanimoto A, Sasaguri T, Arima N, Hashimoto H, Hamada T, Sasaguri Y (1996) Endometrial stromal sarcoma of the uterus with rhabdoid features. Pathol Int 46:231–237PubMedCrossRefPubMedCentralGoogle Scholar
  573. Tanner EJ, Garg K, Leitao MM Jr, Soslow RA, Hensley ML (2012) High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes. Gynecol Oncol 127:27–31.  https://doi.org/10.1016/j.ygyno.2012.06.030. S0090-8258(12)00481-7 [pii]CrossRefPubMedPubMedCentralGoogle Scholar
  574. Tanner EJ, Toussaint T, Leitao MM Jr, Hensley ML, Soslow RA, Gardner GJ, Jewell EL (2013) Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecol Oncol 129:140–144.  https://doi.org/10.1016/j.ygyno.2012.12.036CrossRefPubMedPubMedCentralGoogle Scholar
  575. Tavassoli FA, Norris HJ (1981) Mesenchymal tumours of the uterus. VII. A clinicopathological study of 60 endometrial stromal nodules. Histopathology 5:1–10PubMedCrossRefPubMedCentralGoogle Scholar
  576. Tavassoli FA, Norris HJ (1982) Peritoneal leiomyomatosis (leiomyomatosis peritonealis disseminata): a clinicopathologic study of 20 cases with ultrastructural observations. Int J Gynecol Pathol 1:59–74PubMedCrossRefPubMedCentralGoogle Scholar
  577. Tawfik O, Rao D, Nothnick WB, Graham A, Mau B, Fan F (2014) Transgelin, a novel marker of smooth muscle differentiation, effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Int J Gynecol Obstet Reprod Med Res 1:26–31PubMedPubMedCentralGoogle Scholar
  578. Terada T (2009) Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Pathol 28:29–34.  https://doi.org/10.1097/PGP.0b013e3181808000CrossRefPubMedPubMedCentralGoogle Scholar
  579. Thway K, Fisher C (2015) PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol 19:359–368.  https://doi.org/10.1016/j.anndiagpath.2015.06.003CrossRefPubMedPubMedCentralGoogle Scholar
  580. Tietze L, Gunther K, Horbe A, Pawlik C, Klosterhalfen B, Handt S, Merkelbach-Bruse S (2000) Benign metastasizing leiomyoma: a cytogenetically balanced but clonal disease. Hum Pathol 31:126–128PubMedCrossRefPubMedCentralGoogle Scholar
  581. Tiltman AJ (1985) The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol 4:89–96PubMedCrossRefPubMedCentralGoogle Scholar
  582. Toki T, Shimizu M, Takagi Y, Ashida T, Konishi I (2002) CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol 21:41–47PubMedCrossRefPubMedCentralGoogle Scholar
  583. Tomlinson IP et al (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410.  https://doi.org/10.1038/ng849CrossRefPubMedPubMedCentralGoogle Scholar
  584. Toro JR et al (2003) Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95–106.  https://doi.org/10.1086/376435CrossRefPubMedPubMedCentralGoogle Scholar
  585. Torres VE et al (1995) Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex. Mayo Clin Proc 70:641–648.  https://doi.org/10.1016/s0025-6196(11)63915-3CrossRefPubMedPubMedCentralGoogle Scholar
  586. Tresukosol D, Kudelka AP, Malpica A, Varma DG, Edwards CL, Kavanagh JJ (1995) Leuprolide acetate and intravascular leiomyomatosis. Obstet Gynecol 86:688–692PubMedCrossRefPubMedCentralGoogle Scholar
  587. Tulandi T, Leung A, Jan N (2016) Nonmalignant sequelae of unconfined morcellation at laparoscopic hysterectomy or myomectomy. J Minim Invasive Gynecol 23:331–337.  https://doi.org/10.1016/j.jmig.2016.01.017CrossRefPubMedPubMedCentralGoogle Scholar
  588. Ubago JM, Zhang Q, Kim JJ, Kong B, Wei JJ (2016) Two subtypes of atypical leiomyoma: clinical, histologic, and molecular analysis. Am J Surg Pathol 40:923–933.  https://doi.org/10.1097/pas.0000000000000646CrossRefPubMedPubMedCentralGoogle Scholar
  589. Upadhyaya NB, Doody MC, Googe PB (1990) Histopathological changes in leiomyomata treated with leuprolide acetate. Fertil Steril 54:811–814PubMedCrossRefPubMedCentralGoogle Scholar
  590. van Diest PJ et al (1992) Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23:603–607Google Scholar
  591. van Slegtenhorst M et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805–808PubMedCrossRefPubMedCentralGoogle Scholar
  592. Vang R, Kempson RL (2002) Perivascular epithelioid cell tumor (‘PEComa’) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol 26:1–13PubMedCrossRefPubMedCentralGoogle Scholar
  593. Vang R, Medeiros LJ, Ha CS, Deavers M (2000) Non-Hodgkin’s lymphomas involving the uterus: a clinicopathologic analysis of 26 cases. Mod Pathol 13:19–28.  https://doi.org/10.1038/modpathol.3880005CrossRefPubMedPubMedCentralGoogle Scholar
  594. Varghese L, Arnesen M, Boente M (2006) Primitive neuroectodermal tumor of the uterus: a case report and review of literature. Int J Gynecol Pathol 25:373–377PubMedCrossRefPubMedCentralGoogle Scholar
  595. Venkatraman L, Elliott H, Steele EK, McClelland HR, McCluggage WG (2003) Serous carcinoma arising in an adenofibroma of the endometrium. Int J Gynecol Pathol 22:194–197PubMedCrossRefPubMedCentralGoogle Scholar
  596. Veras E, Malpica A, Deavers MT, Silva EG (2009) Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study. Int J Gynecol Pathol 28:316–321.  https://doi.org/10.1097/PGP.0b013e318193df97CrossRefPubMedPubMedCentralGoogle Scholar
  597. Veras E, Zivanovic O, Jacks L, Chiappetta D, Hensley M, Soslow R (2011) “Low-grade leiomyosarcoma” and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas. Am J Surg Pathol 35:1626–1637.  https://doi.org/10.1097/PAS.0b013e31822b44d2CrossRefPubMedPubMedCentralGoogle Scholar
  598. Vitiello D, McCarthy S (2006) Diagnostic imaging of myomas. Obstet Gynecol Clin N Am 33:85–95.  https://doi.org/10.1016/j.ogc.2005.12.013CrossRefGoogle Scholar
  599. Viville B, Charnock-Jones DS, Sharkey AM, Wetzka B, Smith SK (1997) Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium. Hum Reprod 12:815–822PubMedCrossRefPubMedCentralGoogle Scholar
  600. Vollenhoven B (1998) 1 Introduction: the epidemiology of uterine leiomyomas. Baillieres Clin Obstet Gynaecol 12:169–176.  https://doi.org/10.1016/S0950-3552(98)80059-XCrossRefPubMedPubMedCentralGoogle Scholar
  601. Wachter DL, Wunsch PH, Hartmann A, Agaimy A (2011) Adenomatoid tumors of the female and male genital tract. A comparative clinicopathologic and immunohistochemical analysis of 47 cases emphasizing their site-specific morphologic diversity. Virchows Arch 458:593–602.  https://doi.org/10.1007/s00428-011-1054-5CrossRefPubMedPubMedCentralGoogle Scholar
  602. Wagner AJ et al (2010) Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol 28:835–840.  https://doi.org/10.1200/jco.2009.25.2981CrossRefPubMedPubMedCentralGoogle Scholar
  603. Wallach EE, Vlahos NF (2004) Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 104:393–406.  https://doi.org/10.1097/01.aog.0000136079.62513.39CrossRefPubMedPubMedCentralGoogle Scholar
  604. Wang X, Kumar D, Seidman JD (2006) Uterine lipoleiomyomas: a clinicopathologic study of 50 cases. Int J Gynecol Pathol 25:239–242.  https://doi.org/10.1097/01.pgp.0000192273.66931.29CrossRefPubMedPubMedCentralGoogle Scholar
  605. Wang WL et al (2011) Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases. Am J Surg Pathol 35:522–529.  https://doi.org/10.1097/PAS.0b013e31820ca624CrossRefPubMedPubMedCentralGoogle Scholar
  606. Wang W, Zhu H, Wang J, Wang S, Wang D, Zhao J, Zhu H (2016) Clonality assessment of adenomatoid tumor supports its neoplastic nature. Hum Pathol 48:88–94.  https://doi.org/10.1016/j.humpath.2015.09.032CrossRefPubMedPubMedCentralGoogle Scholar
  607. Warburg O (1956) On the origin of cancer cells. Science 123:309–314PubMedCrossRefPubMedCentralGoogle Scholar
  608. Watanabe K, Suzuki T (2006) Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics. Histopathology 48:563–568.  https://doi.org/10.1111/j.1365-2559.2006.02368.xCrossRefPubMedPubMedCentralGoogle Scholar
  609. Wei MH et al (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43:18–27.  https://doi.org/10.1136/jmg.2005.033506CrossRefPubMedPubMedCentralGoogle Scholar
  610. Weichert W, Denkert C, Gauruder-Burmester A, Kurzeja R, Hamm B, Dietel M, Kroencke TJ (2005) Uterine arterial embolization with tris-acryl gelatin microspheres: a histopathologic evaluation. Am J Surg Pathol 29:955–961PubMedCrossRefPubMedCentralGoogle Scholar
  611. Weissman A, Talmon R, Jakobi P (1993) Cavernous hemangioma of the uterus in a pregnant woman. Obstet Gynecol 81:825–827PubMedPubMedCentralGoogle Scholar
  612. Wolff M, Silva F, Kaye G (1979) Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasms. Report of nine cases, including three males. Am J Surg Pathol 3:325–342PubMedCrossRefPubMedCentralGoogle Scholar
  613. Wolfson AH et al (1994) A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 52:56–62PubMedCrossRefPubMedCentralGoogle Scholar
  614. Wu TI et al (2013) Clinicopathologic parameters and immunohistochemical study of endometrial stromal sarcomas. Int J Gynecol Pathol 32:482–492.  https://doi.org/10.1097/PGP.0b013e3182729131CrossRefPubMedPubMedCentralGoogle Scholar
  615. Xue WC, Cheung AN (2011) Endometrial stromal sarcoma of uterus. Best Pract Res Clin Obstet Gynaecol 25:719–732.  https://doi.org/10.1016/j.bpobgyn.2011.07.004. S1521-6934(11)00108-8 [pii]CrossRefPubMed